<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id><journal-id journal-id-type="publisher-id">nar</journal-id><journal-title-group><journal-title>Nucleic Acids Research</journal-title></journal-title-group><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">10954460</article-id><article-id pub-id-type="pmid">38214235</article-id>
<article-id pub-id-type="doi">10.1093/nar/gkad1258</article-id><article-id pub-id-type="publisher-id">gkad1258</article-id><article-categories><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI00010</subject></subj-group><subj-group subj-group-type="heading"><subject>Nucleic Acid Enzymes</subject></subj-group></article-categories><title-group><article-title>Thiolutin has complex effects <italic toggle="yes">in vivo</italic> but is a direct inhibitor of RNA polymerase II <italic toggle="yes">in vitro</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Qiu</surname><given-names>Chenxi</given-names></name><aff>
<institution>Department of Biochemistry and Biophysics, Texas A&#x00026;M University, College Station</institution>, TX&#x000a0;<addr-line>77843</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name><surname>Arora</surname><given-names>Payal</given-names></name><aff>
<institution>Department of Biochemistry and Biophysics, Texas A&#x00026;M University, College Station</institution>, TX&#x000a0;<addr-line>77843</addr-line>, <country country="US">USA</country></aff><aff>
<institution>Department of Biological Sciences, University of Pittsburgh</institution>, <addr-line>Pittsburgh</addr-line>, PA&#x000a0;<addr-line>15260</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name><surname>Malik</surname><given-names>Indranil</given-names></name><aff>
<institution>Department of Biochemistry and Biophysics, Texas A&#x00026;M University, College Station</institution>, TX&#x000a0;<addr-line>77843</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3469-2936</contrib-id><name><surname>Laperuta</surname><given-names>Amber J</given-names></name><aff>
<institution>Stevenson University</institution>, <addr-line>Stevenson</addr-line>, MD&#x000a0;<addr-line>21153</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name><surname>Pavlovic</surname><given-names>Emily M</given-names></name><aff>
<institution>Earlham College</institution>, <addr-line>Richmond</addr-line>, IN&#x000a0;<addr-line>47374</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name><surname>Ugochukwu</surname><given-names>Scott</given-names></name><aff>
<institution>Texas State University</institution>, <addr-line>San Marcos</addr-line>, TX&#x000a0;78666,&#x000a0;<country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name><surname>Naik</surname><given-names>Mandar</given-names></name><aff>
<institution>Department of Biochemistry and Biophysics, Texas A&#x00026;M University, College Station</institution>, TX&#x000a0;<addr-line>77843</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7518-695X</contrib-id><name><surname>Kaplan</surname><given-names>Craig D</given-names></name><!--craig.kaplan@pitt.edu--><aff>
<institution>Department of Biological Sciences, University of Pittsburgh</institution>, <addr-line>Pittsburgh</addr-line>, PA&#x000a0;<addr-line>15260</addr-line>, <country country="US">USA</country></aff><xref rid="COR1" ref-type="corresp"/></contrib></contrib-group><author-notes><corresp id="COR1">To whom correspondence should be addressed. Tel: +1&#x000a0;412 648 4434; Email: <email>craig.kaplan@pitt.edu</email></corresp></author-notes><pub-date pub-type="collection"><day>21</day><month>3</month><year>2024</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-01-12"><day>12</day><month>1</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>12</day><month>1</month><year>2024</year></pub-date><volume>52</volume><issue>5</issue><fpage>2546</fpage><lpage>2564</lpage><history><date date-type="accepted"><day>29</day><month>12</month><year>2023</year></date><date date-type="rev-recd"><day>18</day><month>12</month><year>2023</year></date><date date-type="received"><day>28</day><month>2</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p></license></permissions><self-uri xlink:href="gkad1258.pdf"/><abstract><title>Abstract</title><p>Thiolutin is a natural product transcription inhibitor with an unresolved mode of action. Thiolutin and the related dithiolopyrrolone holomycin chelate Zn<sup>2+</sup> and previous studies have concluded that RNA Polymerase II (Pol II) inhibition <italic toggle="yes">in vivo</italic> is indirect. Here, we present chemicogenetic and biochemical approaches to investigate thiolutin's mode of action in <italic toggle="yes">Saccharomyces cerevisiae</italic>. We identify mutants that alter sensitivity to thiolutin. We provide genetic evidence that thiolutin causes oxidation of thioredoxins <italic toggle="yes">in vivo</italic> and that thiolutin both induces oxidative stress and interacts functionally with multiple metals including Mn<sup>2+</sup> and Cu<sup>2+</sup>, and not just Zn<sup>2+</sup>. Finally, we show direct inhibition of RNA polymerase II (Pol II) transcription initiation by thiolutin <italic toggle="yes">in vitro</italic> in support of classical studies that thiolutin can directly inhibit transcription <italic toggle="yes">in vitro</italic>. Inhibition requires both Mn<sup>2+</sup> and appropriate reduction of thiolutin as excess DTT abrogates its effects. Pause prone, defective elongation can be observed <italic toggle="yes">in vitro</italic> if inhibition is bypassed. Thiolutin effects on Pol II occupancy <italic toggle="yes">in vivo</italic> are widespread but major effects are consistent with prior observations for Tor pathway inhibition and stress induction, suggesting that thiolutin use <italic toggle="yes">in vivo</italic> should be restricted to studies on its modes of action and not as an experimental tool.</p></abstract><abstract abstract-type="graphical"><title>Graphical Abstract</title><p>
<fig position="float" id="ga1"><label>Graphical Abstract</label><graphic xlink:href="gkad1258figgra1" position="float"/></fig>
</p></abstract><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>National Institutes of Health</institution><institution-id institution-id-type="DOI">10.13039/100000002</institution-id></institution-wrap>
</funding-source><award-id>R01GM097260</award-id><award-id>R35GM144116</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Welch Foundation</institution><institution-id institution-id-type="DOI">10.13039/100000928</institution-id></institution-wrap>
</funding-source><award-id>A-1763</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Texas A&#x00026;M University</institution><institution-id institution-id-type="DOI">10.13039/100007904</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>National Science Foundation</institution><institution-id institution-id-type="DOI">10.13039/100000001</institution-id></institution-wrap>
</funding-source><award-id>DBI-0851611</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Department of Biochemistry and Biophysics</institution><institution-id institution-id-type="DOI">10.13039/100019896</institution-id></institution-wrap>
</funding-source></award-group></funding-group><counts><page-count count="19"/></counts></article-meta></front><body><sec sec-type="intro" id="SEC1"><title>Introduction</title><p>Thiolutin is a historically used transcription inhibitor with potentially multiple modes of action. Thiolutin is&#x000a0;one of a family&#x000a0;of microbially produced dithiolopyrrolone compounds that feature an intra-molecular and redox-sensitive disulfide bond (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). Holomycin is another notable compound in this class. These compounds are thought to be pro-drugs whose anti-microbial action requires reduction of the intramolecular disulfide. Thiolutin has been shown to inhibit bacterial and eukaryotic transcription <italic toggle="yes">in vivo</italic> and has been used to study mRNA stability in multiple species (<xref rid="B3" ref-type="bibr">3&#x02013;6</xref>). However, the mode of action of thiolutin for transcription inhibition remains unclear and complicated (discussed below). In addition, thiolutin appears to affect multiple cellular pathways, including glucose metabolism (<xref rid="B7" ref-type="bibr">7</xref>), Tor signaling (<xref rid="B8" ref-type="bibr">8</xref>), Hog/MAPK pathway signaling (<xref rid="B8" ref-type="bibr">8</xref>), P body formation, mRNA degradation (<xref rid="B9" ref-type="bibr">9</xref>), the oxidative stress response (<xref rid="B10" ref-type="bibr">10</xref>), and proteasome activity (<xref rid="B11" ref-type="bibr">11</xref>). Inhibition of Tor signaling is especially notable as this would induce a rapid reduction in synthesis for many of the most highly transcribed genes in yeast.</p><p>Recent progress has suggested that both thiolutin and holomycin act as redox-sensitive Zn<sup>2+</sup> chelators, providing an explanation for their diverse cellular effects (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B11" ref-type="bibr">11&#x02013;13</xref>). It has been demonstrated <italic toggle="yes">in vitro</italic> that thiolutin and holomycin can be reduced by strong reductants such as DTT or TCEP (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B11" ref-type="bibr">11</xref>) and that reduced thiolutin and holomycin can chelate Zn<sup>2+</sup> (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>). The Zn<sup>2+</sup> chelating activity explains multiple thiolutin induced phenotypes, including alteration of glucose metabolism and proteasome inhibition through inhibition of Zn<sup>2+</sup>-specific metalloproteins (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B11" ref-type="bibr">11</xref>). In addition, two observations suggest a possible mechanism for the thiolutin-induced expression of oxidative stress response genes (<xref rid="B10" ref-type="bibr">10</xref>). First, thiolutin and holomycin appear to require reduction for their activity, and reduction of thiolutin could in turn oxidize the cellular reductant or reducing proteins (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B12" ref-type="bibr">12</xref>). Second, reduced holomycin can be spontaneously oxidized by molecular oxygen, suggesting that holomycin may be a redox cycling compound (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>) and cause accumulation of reactive oxygen species (ROS). Whether thiolutin can act as a redox cycler has not yet been tested, and the cellular reductant(s) for thiolutin or holomycin remain complicated. Earlier reports indicated that glutathione does not reduce holomycin <italic toggle="yes">in vitro</italic> (<xref rid="B1" ref-type="bibr">1</xref>). Recently, levels of glutathione in the range of those <italic toggle="yes">in vivo</italic> have been shown to reduce multiple dithiolopyrrolones <italic toggle="yes">in vitro</italic> and to activate Zn<sup>2+</sup>-chelating activity, consistent with these natural products being pro-chelators requiring reduction (<xref rid="B16" ref-type="bibr">16</xref>). Together, the Zn<sup>2+</sup> chelating and redox activities are consistent with previously observed diversity in thiolutin-induced phenotypes, though transcription inhibition has not been easily explained. Both thiolutin and holomycin have been observed to be inert against RNAPs under conditions where either should be able to chelate Zn<sup>2+</sup>. Furthermore, it is not clear how Zn<sup>2+</sup> chelation would be expected to inhibit transcription. In light of these negative results, transcription inhibition by dithiolopyrrolones was concluded to be a secondary outcome of inhibition of a distinct target, such as the proteasome. For example, thiolutin elicits removal of zinc from Rpn11, an essential deubiquitinase required for the proteasomal processing of ubiquitinated substrates (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>).</p><p>There is extensive evidence for thiolutin inhibition of transcription <italic toggle="yes">in vivo</italic> in multiple species (<xref rid="B17" ref-type="bibr">17&#x02013;19</xref>), though from <italic toggle="yes">in vitro</italic> studies it has been concluded that it inhibits prokaryotic and eukaryotic RNAPs differently. Thiolutin inhibited all three partially purified yeast RNAPs <italic toggle="yes">in vitro</italic> (<xref rid="B20" ref-type="bibr">20</xref>), but failed to inhibit all tested prokaryotic RNAPs <italic toggle="yes">in vitro</italic> (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B21" ref-type="bibr">21</xref>). Similar RNAP inhibition <italic toggle="yes">in vivo</italic> with lack of inhibition <italic toggle="yes">in vitro</italic> has been observed for holomycin (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B22" ref-type="bibr">22</xref>). The recently reported lack of thiolutin inhibition for all three fully purified yeast RNAPs has added further confusion (<xref rid="B11" ref-type="bibr">11</xref>). Therefore, our current state of understanding is that thiolutin and holomycin do not appear to inhibit prokaryotic or fully purified eukaryotic RNAPs, suggesting indirect modes of <italic toggle="yes">in vivo</italic> transcription inhibition. However, without comprehensive assessment of the experimental parameters for different transcription assays, it seems difficult to rule out direct mechanisms of action for thiolutin on eukaryotic RNAPs, as recent work does not satisfactorily explain why thiolutin inhibited all three partially purified yeast RNA polymerases <italic toggle="yes">in vitro</italic> (<xref rid="B20" ref-type="bibr">20</xref>), and how thiolutin inhibited RNAPs prior to template addition, but did not inhibit the template DNA bound RNAPs (<xref rid="B20" ref-type="bibr">20</xref>). This critical order-of-addition requirement for treatment prior to DNA addition is reminiscent of RNAP switch region inhibitor behavior (<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B24" ref-type="bibr">24</xref>) and is consistent with inhibition of a specific and early step in transcription, in contrast to Zn<sup>2+</sup> chelation.</p><p>We can imagine a number of possibilities to reconcile the existing data. First, thiolutin may target a secondary protein, which is present <italic toggle="yes">in vivo</italic> and in partially purified RNA polymerase fractions (<xref rid="B20" ref-type="bibr">20</xref>) but not others (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B21" ref-type="bibr">21</xref>). Second, as predicted (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>), thiolutin may act as a prodrug that is activated <italic toggle="yes">in vivo</italic> and under the <italic toggle="yes">in vitro</italic> conditions of the early report (<xref rid="B20" ref-type="bibr">20</xref>) but not in assays used by others (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B21" ref-type="bibr">21</xref>). To further investigate the mode of action of thiolutin, we have undertaken multiple approaches to screen for thiolutin resistant and sensitive mutants, as similar studies have contributed to understanding of modes of actions of many compounds (<xref rid="B25" ref-type="bibr">25&#x02013;27</xref>), including holomycin (<xref rid="B12" ref-type="bibr">12</xref>). We identify a drug efflux pump functioning in thiolutin resistance and demonstrate that thiolutin treatment appears to induce oxidative stress. We propose that thiolutin likely induces the oxidative stress via oxidizing thioredoxins and possibly also through redox-cycling. In addition, we confirm that reduced thiolutin directly interacts with Zn<sup>2+</sup><italic toggle="yes">in vitro</italic>, consistent with the recent reports on holomycin and thiolutin using different approaches (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>). We also suggest that thiolutin alters cellular Zn<sup>2+</sup> homeostasis in yeast similar to holomycin's effects in <italic toggle="yes">E.coli</italic> (<xref rid="B12" ref-type="bibr">12</xref>) but also find complex interactions with Co<sup>2+</sup>, Cu<sup>2+</sup> and Mn<sup>2+</sup> that are distinct from those of 1,10-phenanthroline, another class of Zn<sup>2+</sup> chelator that inhibits transcription <italic toggle="yes">in vivo</italic> but has been described as an inhibitor <italic toggle="yes">in vitro</italic> through a Cu-chelate (<xref rid="B28" ref-type="bibr">28</xref>).</p><p>Finally, we have revisited <italic toggle="yes">in vitro</italic> biochemical studies with thiolutin and Pol II. We find that thiolutin indeed inhibits Pol II but critically requires the presence of small amounts of Mn<sup>2+</sup>, providing an explanation for disparate results across studies. First, DNA bound Pol II is resistant to thiolutin inhibition, recapitulating Tipper's early study (<xref rid="B20" ref-type="bibr">20</xref>). Second, though thiolutin appears to inhibit a very early step in Pol II transcription, when initiation is bypassed by use of specific nucleic acid scaffold&#x000a0;templates, thiolutin-treated Pol II exhibits pause-prone, slow elongation. Third, high DTT reverses the thiolutin inhibition, suggesting involvement of disulfide bond or redox sensitive covalent chemistry in inhibition. We find that thiolutin appears to inhibit initiation <italic toggle="yes">in vivo</italic> and reduces Pol II occupancy near promoters across many yeast genes. However, the most strongly affected genes are ribosomal protein (RP) genes with ribosome biogenesis (RiBi) genes being less but still strongly affected, consistent with rapid inhibition of Tor pathway signaling and downregulation of Tor pathway targets (<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B30" ref-type="bibr">30</xref>). Elongation of Pol II on genes also appears altered in that Pol II does not appear to completely run off longer genes as it would if elongation were unaltered, or if sole effects of thiolutin were indirectly through distinct signaling pathways. We propose that thiolutin inhibits Pol II transcription directly <italic toggle="yes">in vitro</italic> through a novel mechanism distinct from known Pol II transcription inhibitors but <italic toggle="yes">in vivo</italic> effects are complicated by high levels of pleiotropy. We caution that thiolutin use <italic toggle="yes">in vivo</italic> should be restricted to experiments aiming at understanding its complex modes of action and that any&#x000a0;use as a tool for transcription inhibition <italic toggle="yes">in vivo</italic> would be fraught with undesirable complexity.</p></sec><sec sec-type="materials|methods" id="SEC2"><title>Materials and methods</title><sec id="SEC2-1"><title>Yeast strains and reagents</title><p>Yeast strains and primers used are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>. <italic toggle="yes">YAP1</italic> C-terminal tagging with EGFP and gene deletion strains were constructed as described (<xref rid="B31" ref-type="bibr">31</xref>,<xref rid="B32" ref-type="bibr">32</xref>). Chemicals were commercially obtained from the following: Cayman Chemical (Thiolutin), Gold Biotechnology (DTT, TCEP, 5FOA), Sigma (MnCl<sub>2</sub>), JT Baker (ZnCl<sub>2</sub>), BDH Chemicals (MgCl<sub>2</sub>).</p></sec><sec id="SEC2-2"><title>Variomics screens</title><p>Two separate pools of diploid Variomics libraries were gifts from Dr&#x000a0;Xuewen Pan: one for non-essential and the other for essential genes (<xref rid="B33" ref-type="bibr">33</xref>). The pooled diploid Variomics libraries were grown, sporulated and selected for haploid Variomics libraries as described (<xref rid="B33" ref-type="bibr">33</xref>). Haploid Variomics libraries were subsequently used for the genetic screens. To convert the Variomics libraries into plasmid-free deletion libraries, pooled Variomics libraries (diploid for essential genes and haploid for non-essential genes) were grown in liquid SC media and plated on SC&#x000a0;+&#x000a0;5FOA plates to select against the mutants with the <italic toggle="yes">URA3</italic> plasmids containing the Variomics mutations. The diversity of the libraries were confirmed by deep sequencing of barcodes (&#x02018;uptags&#x02019; and &#x02018;downtags&#x02019;) flanking the deletion cassettes.</p><p>For manual screening of variomics libraries, about 1&#x02013;3&#x000a0;&#x000d7;&#x000a0;10<sup>7</sup> cells were plated on SC&#x000a0;+&#x000a0;10&#x000a0;&#x003bc;g/ml thiolutin plates, and putative&#x000a0;thiolutin resistant candidates were restruck on SC&#x000a0;+&#x000a0;10&#x000a0;&#x003bc;g/ml thiolutin plates to validate the resistance. Plasmids from validated resistant candidates were subsequently recovered for Sanger sequencing to identify putative resistance-conferring variants. We subsequently tested dominance for the repeatedly isolated candidates. The recovered plasmids from all reproducibly isolated candidates were transformed into the wild-type (CKY457) strain, and thiolutin sensitivity for transformants was phenotyped and compared to the empty vector control.</p><p>For high-throughput screens, Variomics libraries were screened on plates, while deletion libraries were screened in liquid, as previously described (<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B33" ref-type="bibr">33</xref>), and three independent screens (biological replicates) were performed. For Variomics screens, each library was screened on SC-URA&#x000a0;+&#x000a0;DMSO, SC-URA&#x000a0;+&#x000a0;8&#x000a0;&#x003bc;g/ml thiolutin or SC-URA&#x000a0;+&#x000a0;10&#x000a0;&#x003bc;g/ml thiolutin&#x000a0;plates. Each biological replicate was screened on 9 plates (6&#x000a0;&#x000d7;&#x000a0;10<sup>7</sup> cells/plate) for 3 days, and cells were scraped to screen for an additional set of 9 plates for 3 days (6&#x000a0;&#x000d7;&#x000a0;10<sup>7</sup> cells/plate). Deletion libraries were grown in liquid SC media to 3&#x000a0;&#x000d7;&#x000a0;10<sup>7</sup> cells/ml and diluted in SC&#x000a0;+&#x000a0;3 &#x003bc;g/ml thiolutin (for haploid non-essential gene deletion library) or SC&#x000a0;+&#x000a0;4&#x000a0;&#x003bc;g/ml thiolutin (for diploid essential gene deletion library) to grow for 20 generations. During the selection, the cells were diluted to 1&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells/ml every five generations to maintain cultures in log phase. For both screens, yeast cells were pooled, and genomic DNA was prepared using a YeaStar Genomic DNA kit (Zymo Research) for subsequent PCR amplification of barcode regions. Amplicons were sequenced by illumina Hiseq2500 in rapid mode. The sequencing reads are deposited in the SRA under the Bioproject PRJNA725683.</p></sec><sec id="SEC2-3"><title>Bar-seq data processing</title><p>Sequencing reads are mapped to the re-annotated barcode sequences (<xref rid="B25" ref-type="bibr">25</xref>) using Bowtie2 (<xref rid="B34" ref-type="bibr">34</xref>) (version 2.2.4) with the -N flag set to 0 and the &#x02013;no-unal flag to suppress unaligned reads for further analyses. Bowtie2 outputs were written into SAM format and further extracted using Samtools (version 1.3.1) (<xref rid="B35" ref-type="bibr">35</xref>). Barcode sequences shorter than 15nts or that&#x000a0;were mapped to multiple reference barcodes were discarded. On average, 98% of sequencing reads were uniquely mapped.</p><p>As with Robinson <italic toggle="yes">et&#x000a0;al.</italic> (<xref rid="B36" ref-type="bibr">36</xref>), we filtered out barcodes with lower than 100 total reads across all samples, since low count barcodes across all conditions were likely from sequencing errors and did not exist. In addition, mutants with less than 20 reads in both treated and the corresponding untreated controls were further filtered out, to exclude large changes from a small amount of reads with low confidence.</p><p>Following Robinson <italic toggle="yes">et&#x000a0;al.</italic> (<xref rid="B36" ref-type="bibr">36</xref>), we added 1 pseudo-count to each barcode count to avoid division by 0, and performed TMM normalization using the edgeR package (version 3.12.1) (<xref rid="B37" ref-type="bibr">37</xref>). For differential abundance analyses, we used edgeR to compute mutant specific dispersions, <italic toggle="yes">P</italic>-value and log transformed abundance changes using exactTest function (default setting). The transformed data were subsequently subjected to differential abundance analyses and clustering analyses. Differential abundance analyses were performed independently for the uptag and downtag sequences, and reproducibility between uptag and downtag data was assessed with Pearson correlation in R. Hierarchical clustering of the thiolutin phenotypic profile to an existing drug response profile for yeast mutants, consisting of 3356 compounds (<xref rid="B26" ref-type="bibr">26</xref>) was performed in Cluster 3.0 (<xref rid="B38" ref-type="bibr">38</xref>), using centered correlation and complete linkage.</p><p>Mutants with significantly altered abundance (<italic toggle="yes">P</italic>&#x0003c;&#x000a0;0.01) were subjected to gene-ontology (GO) analyses as previously reported (<xref rid="B26" ref-type="bibr">26</xref>). In brief, all three GO categories, including biological processes (BP), Molecular Function (MF) and Cellular components (CC), were included in our analyses. Following the previous report (<xref rid="B26" ref-type="bibr">26</xref>), BP and MF GO terms that are too specific (present in less than 5 genes) or too generic (present in &#x0003e;300 genes) were excluded, although smaller GO term groups were allowed for protein complexes (&#x0003e;2 genes) and larger groups (&#x0003e;300 genes) were allowed for cellular components. We computed the GO term enrichment analyses for the significantly resistant or sensitive mutants (<italic toggle="yes">P</italic>&#x0003c;&#x000a0;0.01) using hypergeometric test in R (version 3.2.2, physer function, default setting). Raw counts and <italic toggle="yes">P</italic>-value for each GO term were reported.</p><p>A series of quality controls were performed on the reproducibility among biological replicates, consistency between the two barcodes on each gene deletion (uptag and downtag) for the same strain, common and distinct properties between Variomics and Deletion libraries following a well-established statistical analysis pipeline. A subset of the statistically significant resistant or sensitive mutants were further validated by re-constructing the deletion strain for individual phenotyping.</p></sec><sec id="SEC2-4"><title>Visualization of Yap1 localization under fluorescence microscopy</title><p>Microscopy experiments were performed as previously described (<xref rid="B39" ref-type="bibr">39</xref>). In brief, CKY2038 was grown to mid-log (1&#x02013;2&#x000a0;&#x000d7;&#x000a0;10<sup>7</sup> cells/ml) in SC liquid media and added to the ConA treated perfusion chamber gasket (ThermoFisher, 4 chamber: 19&#x000a0;&#x000d7;&#x000a0;6mm) for treatment at indicated conditions (SC&#x000a0;+&#x000a0;1% DMSO, SC&#x000a0;+&#x000a0;10&#x000a0;&#x003bc;g/ml Thiolutin, SC&#x000a0;+&#x000a0;10&#x000a0;&#x003bc;g/ml Holomycin or SC&#x000a0;+&#x000a0;0.4&#x000a0;mM H<sub>2</sub>O<sub>2</sub>) under the fluorescence microscope. The procedure to prepare the chamber and the microscope setting were the same as previously described.</p></sec><sec id="SEC2-5"><title>Glutathione quantitation assays</title><p>WT yeast (CKY457) cultures were grown (in YPD at 30&#x000b0;C) until mid-log phase (&#x0223c;2&#x000a0;&#x000d7;&#x000a0;10<sup>7</sup> cells/ml), washed and resuspended in the indicated conditions (YPD&#x000a0;+&#x000a0;1% DMSO, YPD&#x000a0;+&#x000a0;10&#x000a0;&#x003bc;g/ml Thiolutin or YPD&#x000a0;+&#x000a0;10&#x003bc;g/ml Holomycin). The suspended cultures were grown at 30&#x000b0;C for one hour, and 5&#x000a0;&#x000d7;&#x000a0;10<sup>7</sup>/ml cells were subject to glutathione (GSH) quantitation. The active and total GSH levels were quantified using the GSH detection kit from Arbor Assays (K006-F5) following the manual. The glutathione disulfide (GSSG) level was calculated by (Total GSH - Active GSH)/2.</p></sec><sec id="SEC2-6"><title>UV-vis assays</title><p>Thiolutin reduction and Zn<sup>2+</sup> chelation reactions were performed in 250&#x000a0;&#x003bc;l reactions with 50&#x000a0;&#x003bc;M Thiolutin, 50&#x000a0;&#x003bc;M ZnCl<sub>2</sub> and 100&#x000a0;mM potassium phosphate buffer (pH&#x000a0;=&#x000a0;6.5), as previously described (<xref rid="B1" ref-type="bibr">1</xref>). Mn<sup>2+</sup> chelation reactions and relevant controls were performed under almost identical conditions except for the 100&#x000a0;mM Tris buffer (pH&#x000a0;=&#x000a0;8) to keep consistent pH with the <italic toggle="yes">in vitro</italic> transcription assays. Each reaction had 250&#x000a0;&#x003bc;l final volume and was quantified in Nanodrop 2000c spectrophotometer using UV-transparent cuvettes.</p></sec><sec id="SEC2-7"><title>Growth, viability and canavanine resistance assays</title><p>Phenotyping of mutants using plate assays were performed as previously described, with indicated addition of chemicals (<xref rid="B40" ref-type="bibr">40</xref>,<xref rid="B41" ref-type="bibr">41</xref>). Yeast liquid growth curve assays with Tecan Infinite F200 plate readers were performed as previously described (<xref rid="B39" ref-type="bibr">39</xref>). For viability assays and canavanine resistance assays, WT yeast strain CKY457 was grown in YPD until mid-log (1&#x02013;2&#x000a0;&#x000d7;&#x000a0;10<sup>7</sup> cells/ml), washed and treated with the indicated conditions (YPD, YPD&#x000a0;+&#x000a0;3&#x000a0;&#x003bc;g/ml thiolutin, YPD&#x000a0;+&#x000a0;5&#x003bc;g/ml thiolutin and YPD&#x000a0;+&#x000a0;10&#x003bc;g/ml thiolutin) for an hour. The viability was quantified by staining the yeast cells in 0.1% Trypan blue staining (GE Healthcare Life Sciences, Catalog Number SV30084.01) for 3 min, and the viability was quantified by counting the fraction of unstained yeast cells under the microscope. At least 300 yeast cells were counted in each repeat. Canavanine resistance frequency was quantified by plating the culture onto YPD and SC-Arg&#x000a0;+&#x000a0;60&#x000a0;&#x003bc;g/ml canavanine plates and dividing the number of canavanine resistant colonies by the number of viable colonies on YPD plates. Three experimental replicates were performed.</p></sec><sec id="SEC2-8"><title>Pol II transcription activity assays</title><p>Pol II was purified using a strain expressing Rpb3 tagged with tandem-affinity tag (TAP), following a procedure as previously described (<xref rid="B42" ref-type="bibr">42</xref>). For initiation experiments DTT was removed from the Pol II buffer prior to the assay using Zeba spin desalting column (Thermo Scientific), though in later experiments this was found to be unnecessary.</p><p>Standard ssDNA transcription assays were performed in the <italic toggle="yes">in vitro</italic> transcription buffer (20&#x000a0;mM Tris&#x02013;HCl pH8, 40&#x000a0;mM KCl, 5&#x000a0;mM MgCl<sub>2</sub>). Each reaction had &#x0223c;0.5 pmol Pol II, 2&#x000a0;&#x003bc;g denatured sheared salmon sperm DNA as the template and 200&#x000a0;&#x003bc;M NTPs except 9&#x000a0;&#x003bc;M cold NTP for labeling with that species (UTP or CTP), 1&#x000a0;&#x003bc;M radioactive &#x003b1;-<sup>32</sup>P UTP or CTP (800 Ci/mmol, Perkin-Elmer) as substrates. The concentration of thiolutin, reductants (DTT or TCEP) and MnCl<sub>2</sub> varies among the experiments (indicated in each figure). In general, 5 &#x003bc;l pre-treatment reactions including DMSO or thiolutin (at 2&#x000d7; final treatment concentration, from 7.5 &#x003bc;g/ml to 60 &#x003bc;g/ml in DMSO), +/&#x02013; MnCl<sub>2</sub> at specified concentration, and DTT (1&#x02013;2&#x000d7; molar equivalent to thiolutin) were composed and incubated for 5 min at room temperature. To these reactions Pol II was added (with or without pre-binding to DNA) in an equal volume of 2X transcription buffer, yielding 10 &#x003bc;l reactions in 1&#x000d7; transcription buffer for thiolutin treatment. These reactions were incubated for 20 min at room temperature. Transcription was initiated by addition of 5 &#x003bc;l DNA/NTP (or just NTP mix in case of DNA&#x000a0;pretreatment) and incubated at room temperature for 30 min and stopped with stop buffer (10&#x000a0;M urea, 5&#x000a0;mM EDTA in TBE). DTT reversal of thiolutin inhibition was accomplished by adding 2 &#x003bc;l 60 mM DTT to 8 &#x003bc;l Pol II treatment reaction at the end of the 20 min&#x000a0;treatment, prior to addition of NTPs/DNA. Transcripts were separated from unincorporated &#x003b1;-<sup>32</sup>P NTPs on 10% acrylamide/7&#x000a0;M urea/TBE gels and visualized with a Bio-Rad Pharos Phosphorimager or GE Typhoon Imager. In vitro transcription elongation assays were performed as previously described (<xref rid="B42" ref-type="bibr">42</xref>), with modifications of time shown&#x000a0;in the figure. 5&#x000a0;&#x003bc;l reactions comprising 5 pmol Pol II, 40 &#x003bc;g/ml thiolutin in DMSO or DMSO alone, 875 &#x003bc;M MnCl<sub>2</sub>, equimolar DTT to thiolutin, 1&#x000d7; transcription buffer, and 3.75 &#x003bc;g BSA were incubated for 20 min at room temperature and then&#x000a0;incubated with 2.5 &#x003bc;l annealed transcription scaffold as described. After 5 min, non-template strand was added for an additional 5 min&#x000a0;incubation. Thiolutin-treated Pol II&#x000a0;+&#x000a0;scaffold was then diluted with additional 1&#x000d7; transcription buffer, MnCl<sub>2</sub>, thiolutin, while untreated Pol II&#x000a0;+&#x000a0;scaffold was diluted with thiolutin containing buffer (made fresh) or control buffer with DMSO. After 20 additional minutes at room temperature, reactions proceeded exactly as described in (<xref rid="B42" ref-type="bibr">42</xref>).</p></sec><sec id="SEC2-9"><title>ChIP-qPCR and ChIP-seq</title><p>(<italic toggle="yes">RPB3::3XFLAG::kanMX4</italic>) subunit of Pol II was used for chromatin immunoprecipitation (ChIP). For <italic toggle="yes">in vivo</italic> elongation assays, Pol II occupancy over a constitutive promoter-driven reporter (<italic toggle="yes">TEF1p::YLR454W</italic>) was determined after treating the cells with thiolutin. Yeast were grown in SC media to mid-log (1&#x000a0;&#x000d7;&#x000a0;10<sup>7</sup> cells/ml) and treated with 10 &#x003bc;g/ml thiolutin for 2, 4, 8 or 10 min&#x000a0;(ChIP-qPCR) or for 1, 2, 4&#x000a0;or 8 min&#x000a0;(ChIP-seq), cross-linked with 1% formaldehyde solution (1% formaldehyde, 10&#x000a0;mM NaCl, 100&#x000a0;&#x003bc;M EDTA and 5&#x000a0;mM HEPES&#x02013;KOH, pH 7.5) for 20 min and quenched by 3&#x000a0;M glycine (final concentration 360&#x000a0;mM) for 5 min. ChIP-qPCR was performed as described previously (<xref rid="B39" ref-type="bibr">39</xref>). In brief, cross-linked cells were disrupted by bead beating and cell lysate was centrifuged at 1500 rpm for 1 min at 4&#x000b0;C to remove cell-debris, followed by centrifugation of chromatin pellets, subsequent washing of pellets (twice) with 1 ml FA buffer (50 mM HEPES&#x02013;KOH pH 7.5, 300 mM NaCl, 1 mM EDTA, 0.1% Triton X-100, 0.01% sodium deoxycholate, 0.1% SDS and 1 mM PMSF) at 14&#x000a0;000 rpm for 20 min at 4&#x000b0;C. Chromatin for ChIP-seq was washed one additional time in special FA buffer lacking SDS and sodium deoxycholate. Chromatin pellets were sonicated using a Diagenode Bioruptor (ChIP-qPCR, 45 cycles&#x02013;3&#x000a0;&#x000d7;&#x000a0;15 cycles; 30 s ON/45 s OFF) or a Diagenode Bioruptor Pico (ChIP-seq, 20 cycles; 30 s ON/30&#x02013;50 s OFF) and used for IP with anti-FLAG antibody (FLAG M2 magnetic beads, Sigma-Aldrich). For ChIP-seq, 1100 &#x003bc;g of chromatin material as determined by BCA assay (Thermo Fisher) was used for each IP with addition of 110 &#x003bc;g <italic toggle="yes">S. pombe</italic> spike-in chromatin from CKP025 (<italic toggle="yes">h- ura4-D18 rpb3+::6gly-3Flag-ura4+</italic>). Concentration of SDS in IP for ChIP-seq after addition of <italic toggle="yes">S. pombe</italic> chromatin was 0.1% and concentration of sodium deoxycholate was 0.01%. SDS and sodium deoxycholate were omitted from all washes for ChIP-seq IPs as they reduce efficiency of FLAG M2 antibody (MilliporeSigma). 10% of the total IP material was used as input. Input or immunoprecipitated DNA was purified by standard phenol&#x02013;chloroform extraction and ethanol precipitated with pellet paint (MilliporeSigma) or glycoblue (ThermoFisher). Immunoprecipitated DNA and 10% of corresponding input DNA (1:10 diluted) were used for qPCR with SsoAdvanced Universal SYBR Green supermix (Bio-Rad) using CFX 96 (Bio-Rad). Pol II fold enrichment was determined by the delta CT method.</p></sec><sec id="SEC2-10"><title>ChIP-seq library preparation</title><p>Libraries for ChIP-seq were prepared with NEBNext Ultra II DNA Library kit (NEB) according to the manufacturer's instructions with the following modifications. Starting DNA for ChIP or input samples was 10 ng. Index primers were from NEBNext Multiplex Oligos for Illumina Dual Index Primer Set 1 and were diluted 1/2.5 before use. Library amplification during indexing amplification was between 6&#x02013;8 cycles Samples were sequenced (paired-end) on an Illumina NextSeq 2000 P2 flow cell.</p></sec><sec id="SEC2-11"><title>ChIP-seq analysis</title><p>Paired-end raw fastq files were first trimmed for TruSeq3-PE-2 adaptors using Trimmomatic 0.38 (<xref rid="B43" ref-type="bibr">43</xref>) to remove adaptor readthrough. FastQC was used for quality control analysis. Adapter-trimmed fastq were then aligned to a hybrid genome combining <italic toggle="yes">S. cerevisiae</italic> and <italic toggle="yes">S. pombe</italic> genomes using bowtie2/2.4.5 (<xref rid="B34" ref-type="bibr">34</xref>), allowing 1 mismatch and disallowing insert size&#x000a0;&#x0003e;1000 (&#x02018;bowtie2 -q -N 1 -X 1000 &#x02013;x&#x02019;). The hybrid genome was generated by combining <italic toggle="yes">S. cerevisiae</italic> genome version R64-3-1 with <italic toggle="yes">S. pombe</italic> genome 2018-9-4, after appending a suffix of &#x02018;pom_&#x02019; to <italic toggle="yes">S. pombe</italic> chromosomes to allow reads mapping to <italic toggle="yes">S. pombe</italic> to be filtered later. Sam files generated from bowtie2 alignment were then converted to bam, which were then sorted and indexed using bamtools. Duplicates were then removed by picard 2.8.12, followed by indexing of newly generated bam files. Subsequent to duplicate removal, reads aligned to hybrid genome were segregated into separate species-specific (<italic toggle="yes">S. cerevisiae</italic> or <italic toggle="yes">S. pombe</italic>) input or IP bam files (&#x02018;samtools idxstats&#x000a0;&#x0003c;&#x000a0;non_duplicated-hybrid.bam&#x0003e; | cut -f 1 | grep -v &#x02018;pom_&#x02019; | xargs samtools view -b&#x000a0;&#x0003c;&#x000a0;non_duplicated-hybrid.bam&#x0003e; &#x0003e; &#x0003c;output_S.ce.bam&#x0003e;&#x02019;; &#x02018;samtools idxstats&#x000a0;&#x0003c;&#x000a0;non_duplicated-hybrid.bam&#x0003e; | cut -f 1 | grep &#x02018;pom_&#x02019; | xargs samtools view -b&#x000a0;&#x0003c;&#x000a0;non_duplicated-hybrid.bam&#x0003e; &#x0003e; &#x0003c;output_pombe.bam&#x0003e;&#x02019;). Bams were then indexed using samtools/1.14 (<xref rid="B35" ref-type="bibr">35</xref>). This segregation of species-specific reads allows counting species specific reads in both input and IP bam files for normalization factor quantification. Total number of unique reads (samtools flag -F 260) per bam file of <italic toggle="yes">S. cerevisiae</italic> and <italic toggle="yes">S. pombe</italic> were counted for both input and IP data for calculating normalization factor combining input and spike-in reads, using an R script. The normalization factor was estimated following method of : (INPUT_Sp_Counts/100000000)/((Sp_Counts/100000000) * (INPUT_Sc_Counts/100000000)) (<xref rid="B44" ref-type="bibr">44</xref>). These factors were then used to scale the <italic toggle="yes">S.cerevisiae</italic> IP bams to generate scaled or normalized bigwigs using bamCoverage function of deeptools/3.3.0. Wiggletools/1.2.11 (<xref rid="B45" ref-type="bibr">45</xref>,<xref rid="B46" ref-type="bibr">46</xref>) was then used to generate mean bedgraphs of three replicates which were then converted to mean bigwigs using bedGraphtoBigWig of kentutils/v.370 (<xref rid="B47" ref-type="bibr">47</xref>). Differential bigwigs were generated by log<sub>2</sub> operation function of bigwigCompare under the deeptools/3.3.0 package which were then used for generating heatmaps (<xref rid="B46" ref-type="bibr">46</xref>).</p></sec><sec id="SEC2-12"><title>
<sup>1</sup>H-NMR characterization of thiolutin reduction and metal binding</title><p>Thiolutin stock solution for NMR experiments was freshly prepared by dissolving thiolutin in DMSO-d6. Thiolutin reduction study was performed using freshly prepared DTT in an NMR tube at the final sample concentrations of 1.5&#x000a0;mM thiolutin, 7.5&#x000a0;mM DTT, 15&#x000a0;mM Tris (pH&#x000a0;=&#x000a0;8.0) and 10% D<sub>2</sub>O. <sup>1</sup>H-NMR spectra were collected immediately using 500&#x000a0;MHz Bruker Avance II spectrometer at 25&#x000b0;C. For Zn<sup>2+</sup> and Mn<sup>2+</sup> chelation experiments, Zn<sup>2+</sup> or Mn<sup>2+</sup> were added at a final concentration of 7.5&#x000a0;mM 1 min&#x000a0;after thiolutin reduction by DTT and were incubated at room temperature for 2 min before the acquisition of <sup>1</sup>H-NMR spectra.</p></sec></sec><sec sec-type="results" id="SEC3"><title>Results</title><sec id="SEC3-1"><title>Thiolutin or reduced thiolutin alone fail to inhibit fully purified Pol II <italic toggle="yes">in vitro</italic></title><p>Recent publications suggest that thiolutin does not directly inhibit Pol II, in contrast to classic <italic toggle="yes">in vitro</italic> transcription experiments demonstrating thiolutin inhibition of partially purified yeast extract fractions containing Pol I, II&#x000a0;or III (<xref rid="B20" ref-type="bibr">20</xref>). We set out to understand this discrepancy by first examining thiolutin inhibition of purified Pol II. Given that thiolutin and holomycin activities could be sensitive to reduction of the disulfide bond by DTT (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>) (Figure <xref rid="F1" ref-type="fig">1A</xref>), we removed DTT from the <italic toggle="yes">in vitro</italic> transcription reaction and performed thiolutin treatment with or without molar equivalents of DTT (Figure <xref rid="F1" ref-type="fig">1B</xref>). Under the buffer conditions employed here, we failed to observe thiolutin inhibition of Pol II, with DTT having no effect (Figure <xref rid="F1" ref-type="fig">1B</xref>). While these results are consistent with assertions that thiolutin does not directly target Pol II, they might similarly be explained by the absence of a cofactor or subtleties in experimental conditions between <italic toggle="yes">in vitro</italic> assays. We therefore set out to screen for potential co-factors while these biochemical assays are revisited below.</p><fig position="float" id="F1"><label>Figure 1.</label><caption><p>Thiolutin or reduced thiolutin alone fails to inhibit purified yeast Pol II <italic toggle="yes">in vitro</italic>. (<bold>A</bold>) Thiolutin and holomycin structures. (<bold>B</bold>) Thiolutin, or thiolutin treated with equimolar DTT, show no inhibition of Pol II transcription <italic toggle="yes">in vitro</italic>. Transcription activity assay was performed with ssDNA as the template and NTPs, including <sup>32</sup>P labeled UTP. The transcribed <sup>32</sup>P containing RNA was separated from free <sup>32</sup>P UTPs on 10% polyacrylamide gels for visualization. Experiments were performed with at least three times, and a representative experiment is shown.</p></caption><graphic xlink:href="gkad1258fig1" position="float"/></fig></sec><sec id="SEC3-2"><title>Three independent genetic screens for thiolutin resistant and sensitive mutants</title><p>To gain insights into factors controlling the cellular response to thiolutin, we performed three independent genetic screens for modifiers of thiolutin sensitivity (Figure <xref rid="F2" ref-type="fig">2A</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1A</xref>). First, we performed a conventional forward genetic screen for thiolutin resistant mutants through UV mutagenesis followed by thiolutin resistance selection. The causal mutations for thiolutin resistance were identified by bulk segregant analysis and whole genome sequencing (<xref rid="B48" ref-type="bibr">48</xref>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1A</xref>). Second, we screened a yeast Variomics library for individual thiolutin resistant candidates (<xref rid="B33" ref-type="bibr">33</xref>). The Variomics library contained random mutations for almost all yeast genes cloned into a CEN-based plasmid and expressed in strains with the relevant endogenous gene deleted. The CEN-based plasmid used is known to propagate at 1&#x02013;2 copies/cell and could result in increased gene dosage (<xref rid="B49" ref-type="bibr">49</xref>). Mutants from the forward genetics screen or those reproducibly isolated from the manual Variomics screens were re-tested for resistance (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1B,&#x000a0;C</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S1</xref>, <xref rid="sup1" ref-type="supplementary-material">S2</xref>). Third, we performed a set of high-throughput screens using both pooled Variomics and deletion libraries using barcode-sequencing (Bar-seq) (<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>) (Figure <xref rid="F2" ref-type="fig">2A</xref>, Materials and methods), where the thiolutin resistant and sensitive mutants were identified by quantifying changes of mutant-linked DNA barcode frequency under thiolutin-treated or control conditions (26,36). Overall, our data exhibited excellent reproducibility (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2</xref>) and revealed valuable common and distinct features between Variomics (putative gain-of-function (GOF) and loss-of-function (LOF) mutants combined) and deletion (LOF mutants) libraries (see Materials and methods). We have revealed contribution of multidrug resistance (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1B&#x02013;E</xref>, <xref rid="sup1" ref-type="supplementary-material">S3</xref>), oxidative stress response (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1F, G</xref>, <xref rid="sup1" ref-type="supplementary-material">S5</xref>), multiple divalent metal homeostasis/trafficking pathways (Figures <xref rid="F2" ref-type="fig">2</xref>&#x000a0;and&#x000a0;<xref rid="F3" ref-type="fig">3</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S7</xref> and&#x000a0;<xref rid="sup1" ref-type="supplementary-material">S8</xref>) as well as the proteasome to thiolutin resistance (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S6</xref>), and we have further genetically dissected a subset of these pathways. These data collectively support that reduction and manganese or other metals appear to contribute to the thiolutin inhibitory activity, supporting a model that reduction and manganese are both required for thiolutin inhibition of Pol II <italic toggle="yes">in vitro</italic>, tested in subsequent biochemical experiments (Figures <xref rid="F4" ref-type="fig">4</xref>,<xref rid="F5" ref-type="fig">5</xref>). Each of these pathways is discussed below.</p><fig position="float" id="F2"><label>Figure 2.</label><caption><p>Mutations in diverse cellular pathways confer resistance/sensitivity to thiolutin. (<bold>A</bold>) Four libraries (Variomics libraries for non-essential or essential genes, Deletion libraries for non-essential or essential genes) were used for screening thiolutin resistant or sensitive mutants. Changes in abundance in the library was detected by deep sequencing of the PCR amplicon of the barcode region (Bar-seq). Variomics libraries consist of random gene variants and can be used to screen for both gain-of-function (GOF) and loss-of-function (LOF) alleles, whereas &#x02018;Deletion&#x02019; libraries consist of single-gene-deleted mutants that can be used to screen for complete LOF mutants. (<bold>B</bold>) Different thiolutin resistant or sensitive mutant classes are revealed in the Bar-seq based screenings of pooled Variomics and Deletion libraries. (<bold>C</bold>) Thiolutin induced phenotypic profile in the pooled deletion libraries co-clusters with drugs with signature of &#x02018;mitochondrial response to ROS&#x02019; (<xref rid="B26" ref-type="bibr">26</xref>) and bathophenanthroline, a metal chelator. 4683 deletion mutants&#x02019; responses (in columns) to 3356 compounds (in rows) were used for hierarchical clustering, but only the thiolutin closely correlated compounds are shown in this figure for clarity. Resistant strains: yellow; sensitive strains: blue.</p></caption><graphic xlink:href="gkad1258fig2" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><p>Divalent metals cations appear to alter thiolutin sensitivity <italic toggle="yes">in vivo</italic> and interact with reduced thiolutin <italic toggle="yes">in vitro</italic>. (A&#x02013;D) 10-fold serial dilutions of yeast strains spotted onto different types of media to examine thiolutin sensitivity. (<bold>A</bold>) <italic toggle="yes">zap1&#x00394;</italic> is hypersensitive to thiolutin. (<bold>B</bold>) <italic toggle="yes">pmr1&#x00394;</italic> is hypersensitive to thiolutin. (<bold>C</bold>) Mn<sup>2+</sup> supplementation exacerbates WT yeast sensitivity to thiolutin. (<bold>D</bold>) Distinct sensitivities of thiolutin and 1,10-phenanthroline to Co<sup>2+</sup>, Cu<sup>2+</sup>&#x000a0;and Mn<sup>2+</sup> and differential interactions with gene deletions. (<bold>E</bold>) Reduced thiolutin was incubated with a selection of divalent metal cations and UV absorbance was analyzed. Zn<sup>2+</sup>, Mn<sup>2+</sup>&#x000a0;and Cu<sup>2+</sup>, but not Mg<sup>2+</sup>, interact with reduced thiolutin, as evident by alteration of the UV spectra of reduced thiolutin.</p></caption><graphic xlink:href="gkad1258fig3" position="float"/></fig><fig position="float" id="F4"><label>Figure 4.</label><caption><p>Apparent thiolutin/Mn<sup>2+</sup> complex inhibits Pol II transcription <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>. (<bold>A</bold>) Thiolutin requires both DTT (reductant) and Mn<sup>2+</sup> to inhibit Pol II transcription <italic toggle="yes">in vitro</italic>. A representative of multiple experiments is shown. Quantifications of this and a wide range of experimental conditions for thiolutin inhibition are shown in (C,D). (<bold>B</bold>) Pre-binding to DNA renders Pol II resistant to Thiolutin/Mn<sup>2+</sup> complex. This gel is representative of multiple independent experiments. (<bold>C</bold>) Quantification of thiolutin inhibition under a number of experimental conditions. Thiolutin (60 &#x003bc;g/ml) inhibition of Pol II requires DTT and Mn2&#x000a0;+&#x000a0;and is blocked by pre-incubation of Pol II with DNA or with excess (12 mM) DTT added after Pol II treatment with thiolutin. All reactions are compared to baseline for individual Pol II in particular experiment, which is activity of Pol II plus vehicle (15% DMSO final). Different symbols indicate three independent Pol II purifications used in experiments. Note that variability in fraction of Pol II inhibited by thiolutin appears to track with Pol II purification (&#x025b4;&#x02022; Pol II consistently more inhibited than &#x02b25;). Error bars are mean +/&#x02013; standard deviation. Statistical analysis for selected pairs is one-way ANOVA with multiple comparisons controlling for false discovery rate (0.01) (method of Benjamini, Krieger, Yekutieli (<xref rid="B110" ref-type="bibr">110</xref>)). **** <italic toggle="yes">P</italic>&#x0003c;&#x000a0;0.0001, ***&#x000a0;<italic toggle="yes">P</italic>&#x0003c;&#x000a0;0.0002, * <italic toggle="yes">P</italic>&#x0003c;&#x000a0;0.0332. (<bold>D</bold>) Quantification of thiolutin inhibition at lower thiolutin/DMSO concentrations and additional controls. All reactions are compared to baseline for individual Pol II in particular experiment, which is activity of Pol II in absence of drug or vehicle. Different symbols indicate two separate Pol II purifications (symbols here match Pol II purifications in (C). Statistical analysis for selected pairs is one-way ANOVA with multiple comparisons controlling for false discovery rate (0.01) (method of Benjamini, Krieger, Yekutieli (<xref rid="B110" ref-type="bibr">110</xref>)). **** <italic toggle="yes">P</italic>&#x0003c;&#x000a0;0.0001. (<bold>E</bold>) <italic toggle="yes">In vitro</italic> elongation assay for thiolutin-treated Pol II. (Top) Schematic indicates three assembly pathways for making elongation complexes on nucleic acid scaffolds in the absence of thiolutin, incubation with thiolutin after elongation complex assembly, or before elongation complex assembly. (Bottom) Thio/Mn<sup>2+</sup> inhibited Pol II can be directly assembled into a distinct and slow elongating complex, but only if Pol II is treated with thiolutin prior to complex assembly. Two experimental replicates were performed, and a representative replicate is shown. Duration times for incubation with NTPs were 0, 10, 30, 120, 300 and 600 s.</p></caption><graphic xlink:href="gkad1258fig4" position="float"/></fig><fig position="float" id="F5"><label>Figure 5.</label><caption><p>Thiolutin reduces Pol II occupancy genome wide. (<bold>A</bold>) Thiolutin inhibits Pol II occupancy at a <italic toggle="yes">TEF1</italic> promoter-driven <italic toggle="yes">YLR454W</italic> reporter <italic toggle="yes">in vivo</italic>. Schematic indicates positions of PCR primers for chromatin immunoprecipitation-quantitative PCR (ChIP-qPCR) for a FLAG-tagged Rpb3 subunit of Pol II at a reporter gene representing a long transcription unit. Thiolutin (10&#x000a0;&#x003bc;g/ml) was added to cells for indicated times prior to crosslinking for ChIP. Three experimental replicates were performed, and error bars represent standard deviation of the mean. (<bold>B</bold>) Schematic of Pol II ChIP-seq experiment thiolutin treatment for the indicated times (control sample with addition of vehicle DMSO was for 8 min treatment). (<bold>C</bold>) Genome-wide decreases of Pol II occupancy at genes separated into quintile based on normalized Pol II occupancy in untreated cells from highest (Q1) to lowest (Q5). Quintiles are &#x0223c;846 genes each. Genes are rank ordered from shortest to longest with annotated gene 3&#x02032;-ends indicated with the dashed line. (<bold>D</bold>) The majority of genes show decreases in Pol II occupancy as determined by fold change in normalized Pol II occupancy per base within each gene. Genes separated by class indicate that ribosomal protein (RP) genes show greater Pol II decreases than do ribosomal biogenesis (RiBi) than do other highly expressed genes in Q1. (<bold>E</bold>) Decrease in Pol II occupancy (y axis) shows some correlation with initial occupancy levels (x-axis) with RP genes showing special sensitivity to thiolutin treatment.</p></caption><graphic xlink:href="gkad1258fig5" position="float"/></fig></sec><sec id="SEC3-3"><title>Functional dissection of the multidrug resistance (MDR) and oxidative stress response (OSR) pathways in response to thiolutin</title><p>We identified thiolutin resistant strains harboring mutations in MDR and OSR genes from all three genetic screens. These results are perhaps not surprising given that yeast has well characterized MDR pathways that sense and pump out the toxic small molecules as a self-protection mechanism, along with recent reports that thiolutin and holomycin activities require reduction <italic toggle="yes">in vitro</italic> (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>). Reduction of thiolutin may itself oxidize cellular proteins and cause oxidative stress. In addition, it has been reported that reduced holomycin may act as a redox cycler, which could possibly generate ROS. Consistent with redox activity, thiolutin appeared to induce expression of several OSR genes (<xref rid="B10" ref-type="bibr">10</xref>). However, it has not been examined how thiolutin interacts with either MDR or OSR pathways. In light of our isolated thiolutin resistant mutants, we functionally dissected control of thiolutin sensitivity by these pathways. From both manual Variomics and forward genetic screens, we isolated multiple mutants in <italic toggle="yes">YAP1</italic> and <italic toggle="yes">YRR1</italic>, encoding transcription factors that have been implicated in OSR and/or MDR, respectively (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1C</xref>). In addition, we also isolated mutants in the MDR efflux pump gene <italic toggle="yes">SNQ2</italic> from the manual Variomics screen. Finally, from high-throughput Bar-seq screens, we identified distinct thiolutin resistance and sensitivity in additional mutants linked to MDR transcription factors or efflux pumps (Figure <xref rid="F2" ref-type="fig">2B</xref>). Several lines of evidence suggested that the isolated thiolutin resistant MDR mutants were GOF mutations. First, isolated <italic toggle="yes">yap1</italic> mutations were clustered in C-terminal regions, where a variety of mutants are known to cause GOF (<xref rid="B50" ref-type="bibr">50&#x02013;54</xref>). Second, isolated MDR mutants from the manual Variomics screen were dominant or functioned through increased dosage (overexpression) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S3</xref>). Third, in Bar-seq screens, we found Variomics mutants in several MDR genes (<italic toggle="yes">YAP1, YRR1, SNQ2</italic>) conferred thiolutin resistance whereas deletion of the same genes either conferred sensitivity or had no strong effect (Figure <xref rid="F2" ref-type="fig">2B</xref>), consistent with these MDR Variomics mutants being different from the gene deletion mutants (complete LOF).</p><p>To determine the nature of identified MDR mutants from our screens, we constructed a series of MDR gene deletion mutants and tested their sensitivity to thiolutin (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1D</xref>). We found that none of the tested deletion mutants was thiolutin resistant (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1D</xref>). The lack of resistance for all the tested MDR deletion strains is consistent with the isolated thiolutin resistant MDR mutants from Variomics and forward genetics screens increasing MDR activity. In addition, <italic toggle="yes">pdr1&#x00394;</italic> and <italic toggle="yes">snq2&#x00394;</italic> conferred hypersensitivity to thiolutin (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1D</xref>), consistent with the Pdr1 and Snq2 functions in promoting thiolutin resistance for WT strains. Together, we conclude that the MDR transcription factor Pdr1 is the major transcription factor promoting efflux of thiolutin from the cell, whereas neither Yrr1 nor Yap1 appeared to promote baseline resistance, given that <italic toggle="yes">yap1&#x00394;</italic> and <italic toggle="yes">yrr1&#x00394;</italic> did not confer thiolutin hypersensitivity. However, increased Yap1 or Yrr1 activities through mutations or dosage may increase efflux pump expression to promote thiolutin resistance, through their known linkage to many multidrug efflux pumps (<xref rid="B55" ref-type="bibr">55&#x02013;57</xref>).</p><p>Holomycin did not inhibit yeast cell growth at low concentration (<xref rid="B22" ref-type="bibr">22</xref>), and we recapitulated these observations (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S4A</xref>). Given that structurally similar compounds may have different cell permeability and efflux efficiency, we asked whether the same set of MDR deletion strains conferred sensitivity to holomycin, but failed to observe any (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S4A</xref>). This observation suggested that the lack of holomycin sensitivity may not be due to selective efficiency of drug efflux, although we cannot rule out the possibility that thiolutin and holomycin may be transported by different efflux pumps.</p><p>In addition to MDR pathways, we also identified thiolutin-modulating mutations in OSR-related genes, including <italic toggle="yes">YAP1</italic> (discussed above) and genes in the thioredoxin pathway. Thioredoxins are a series of small anti-oxidant proteins that primarily function in reducing specific cysteines in client proteins (reviewed in (<xref rid="B58" ref-type="bibr">58</xref>) and references therein), and in turn are themselves reduced by thioredoxin reductases (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1F</xref>). In yeast, there are two thioredoxin reductases (cytoplasmic Trr1 and mitochondrial Trr2) and three thioredoxins (cytoplasmic Trx1, Trx2; mitochondrial Trx3) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1F</xref>). Mutants in <italic toggle="yes">TRR1</italic> were reproducibly isolated from our manual Variomics screen (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1B,&#x000a0;E</xref>; <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). In addition, <italic toggle="yes">TRR1*</italic> and <italic toggle="yes">TRX1*</italic> plasmid bearing strains obtained from from high-throughput screening of Variomics libraries were resistant to thiolutin but not <italic toggle="yes">trr1&#x00394;</italic> or <italic toggle="yes">trx1&#x00394;</italic> were not (Figures <xref rid="F2" ref-type="fig">2B</xref>), suggesting that <italic toggle="yes">TRR1*</italic> and <italic toggle="yes">TRX1*</italic> plasmids in the Variomics library could be GOF due to specific mutation or increased dosage of the plasmid.</p><p>
<italic toggle="yes">TRR1</italic> was found to be essential in large scale gene deletion analysis (<xref rid="B59" ref-type="bibr">59</xref>) but nonessential in classical genetic experiments (<xref rid="B60" ref-type="bibr">60&#x02013;64</xref>). To understand the nature of <italic toggle="yes">TRR1</italic> function in thiolutin resistance/sensitivity, we constructed a <italic toggle="yes">trr1&#x00394;</italic> strain to directly test its thiolutin sensitivity (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1G</xref>). Interestingly, <italic toggle="yes">trr1&#x00394;</italic> conferred hypersensitivity to thiolutin (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1G</xref>), consistent with Trr1 activity antagonizing thiolutin and specific <italic toggle="yes">TRR1*</italic> mutants or increased Trr1 dosage enhancing this antagonism. The Trr1 function in antagonizing thiolutin also suggests that our isolated <italic toggle="yes">yap1</italic> alleles could confer thiolutin resistance through promoting <italic toggle="yes">TRR1</italic> expression, among other mechanisms.</p><p>We conceive of <italic toggle="yes">trr1&#x00394;</italic> hypersensitivity to thiolutin in two ways. It could be due to loss of Trr1 function in directly counteracting thiolutin activity or the accumulation of oxidized thioredoxins, or both. The observed <italic toggle="yes">TRX1*</italic>-linked thiolutin resistance in high-throughput Variomics screens suggested critical functions of thioredoxin(s) in thiolutin resistance downstream of <italic toggle="yes">TRR1</italic>. Therefore, we examined thioredoxin deletions directly for thiolutin resistance. We found that the <italic toggle="yes">trx1&#x00394;</italic>, <italic toggle="yes">trx2&#x00394;</italic>, or <italic toggle="yes">trx1&#x00394; trx2&#x00394;</italic> mutants did not confer thiolutin sensitivity (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1G</xref>). In contrast, <italic toggle="yes">trx1&#x00394; trx2&#x00394;</italic> conferred thiolutin resistance, and further, suppressed thiolutin hypersensitivity of <italic toggle="yes">trr1&#x00394;</italic> (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1G</xref>), consistent with the hypothesis that <italic toggle="yes">trr1&#x00394;</italic> hypersensitivity to thiolutin is due to accumulation of oxidized thioredoxins. The observed <italic toggle="yes">trx1&#x00394; trx2&#x00394;</italic> thiolutin resistance reveals a&#x000a0;critical requirement of Trx1 and Trx2 for thiolutin activity <italic toggle="yes">in vivo</italic> and suggests that Trx1 and Trx2 may function either directly or indirectly in thiolutin reduction. However, further experiments are needed to test the direct thiolutin reduction by Trx1 or Trx2.</p><p>Thiolutin resistance conferred by <italic toggle="yes">yap1</italic> alleles and thioredoxin mutants suggests possible connections to OSR. Therefore, we set to test the roles of two additional OSR genes, <italic toggle="yes">TSA1</italic>, encoding a thioredoxin peroxidase, and <italic toggle="yes">SOD1</italic>, encoding a cytosolic copper-zinc superoxide dismutase, in thiolutin resistance. Interestingly, <italic toggle="yes">sod1&#x00394;</italic>, but not <italic toggle="yes">tsa1&#x00394;</italic>, conferred hypersensitivity to thiolutin (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1G</xref>). Given that holomycin is a known redox cycler, we asked if simple addition of H<sub>2</sub>O<sub>2</sub> could mimic the thiolutin effect in tested thioredoxin and OSR gene deletion mutants (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1G</xref>). Thiolutin sensitivities in tested strains were distinct from H<sub>2</sub>O<sub>2</sub> sensitivities, suggesting distinct effects on cellular function. Finally, we tested if yeast could be sensitized to holomycin by the same set of mutants (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S4</xref>). Interestingly, <italic toggle="yes">trr1&#x00394;</italic> and <italic toggle="yes">sod1&#x00394;</italic> were slightly sensitive to 10 &#x003bc;g/ml holomycin (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S4</xref>), suggesting that the induction of oxidative stress could be general property of dithiolopyrrolone compounds and that yeast are at least somewhat permeable to holomycin.</p></sec><sec id="SEC3-4"><title>Thiolutin induces apparent oxidative stress</title><p>Multiple lines of evidence presented above indicated that thiolutin may induce oxidative stress and increased Yap1 function may promote thiolutin resistance. Yap1 functions by sensing cellular oxidants through its C-terminal cysteines, causing it to translocate into the nucleus and up-regulating a series of OSR genes to counteract oxidants upon oxidative stress (<xref rid="B50" ref-type="bibr">50&#x02013;54</xref>). Therefore, nuclear localization of Yap1 is in general a sign of increased Yap1 function and OSR (<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B53" ref-type="bibr">53</xref>,<xref rid="B54" ref-type="bibr">54</xref>). To test whether thiolutin treatment caused nuclear translocation of Yap1, we fused <italic toggle="yes">YAP1</italic> to sequence encoding EGFP on the Yap1 C-terminus, and monitored Yap1::EGFP localization after thiolutin treatment. Thiolutin indeed induced Yap1::EGFP nuclear localization, consistent with induction of oxidative stress, although the thiolutin-induced Yap1::EGFP nuclear translocation appeared to be slower and weaker than that induced by H<sub>2</sub>O<sub>2</sub> (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures&#x000a0;S5</xref>). In addition, thiolutin depleted total glutathione within an hour of treatment (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S6A</xref>). However, thiolutin depleted both active GSH and GSSG, a behavior similar to glutathione synthesis defective mutants but distinct from several well-known oxidants such as H<sub>2</sub>O<sub>2</sub> and menadione (<xref rid="B65" ref-type="bibr">65&#x02013;67</xref>). In contrast, a&#x000a0;holomycin effect was&#x000a0;weak at best on Yap1 localization and did not affect cellular glutathione levels (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S6A</xref>), consistent with the lack of growth inhibition by holomycin and distinct activities or trafficking in yeast between the two structurally similar compounds.</p><p>Previous studies suggested that the reduced holomycin was spontaneously re-oxidized when exposed to air (<xref rid="B1" ref-type="bibr">1</xref>), consistent with the behavior of redox-cycling compounds. To test if thiolutin exhibited similar behavior, we monitored thiolutin reduction and re-oxidation by its unique UV absorbance due to the conjugated ene-dithiol groups (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S6B, C</xref>), as with the recent reports (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>). Thiolutin could be reduced by DTT or TCEP, but not equimolar glutathione (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S6B</xref>), consistent with the behavior of holomycin (<xref rid="B1" ref-type="bibr">1</xref>). Reduced thiolutin could be also re-oxidized (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S6C</xref>), suggesting that thiolutin can act as a redox-cycler, similar to holomycin (<xref rid="B1" ref-type="bibr">1</xref>). Together, thiolutin induced the Yap1 nuclear accumulation and hypersensitivity of <italic toggle="yes">sod1&#x00394;</italic> and <italic toggle="yes">trr1&#x00394;</italic> mutant <italic toggle="yes">in vivo</italic> and appeared to be a redox cycler <italic toggle="yes">in vitro</italic>, consistent with the induction of oxidative stress.</p><p>DNA damage can be a consequence of redox-cycling and can lead to transcription inhibition and cytotoxicity (<xref rid="B68" ref-type="bibr">68</xref>,<xref rid="B69" ref-type="bibr">69</xref>). We asked if thiolutin treatment could cause DNA damage or decrease viability. We did not observe an increase in mutation rate as measured by resistance to canavanine, consistent with little or no effect on DNA damage rates, nor did we observe a viability defect over the period of treatment (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S6D, E</xref>). The lack of viability defect is consistent with an early report showing that thiolutin inhibition was reversible after several hours&#x02019; treatment (<xref rid="B70" ref-type="bibr">70</xref>). Together, we suggest that thiolutin is a redox cycler <italic toggle="yes">in vitro</italic> and possibly also <italic toggle="yes">in vivo</italic> but does not appear to inhibit transcription through widespread DNA damage.</p></sec><sec id="SEC3-5"><title>Additional cellular pathways are involved in thiolutin resistance</title><p>The high-throughput screens of pooled yeast Variomics and deletion libraries, compared to conventional forward genetics and manual Variomics screens, revealed several additional pathways in thiolutin resistance (Figure <xref rid="F2" ref-type="fig">2B</xref>). We isolated mutants involved in metal homeostasis, SWI/SNF complex, proteasome, ribosomal RNA biogenesis, and small ribosomal subunits (Figure <xref rid="F2" ref-type="fig">2B</xref>). Many observations from the Variomics screens were already independently confirmed from two conventional screens, direct deletion analyses, or the existing literature (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S1</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>). For example, deletion of SWI/SNF complex subunits <italic toggle="yes">SWI3</italic> and <italic toggle="yes">SNF12</italic> have been shown to confer sensitivity to a variety of divalent metals including Mn<sup>2+</sup>, Zn<sup>2+</sup>, Co<sup>2+</sup> and Cd<sup>2+</sup> (<xref rid="B71" ref-type="bibr">71&#x02013;75</xref>), consistent with thiolutin perturbation of metal homeostasis (discussed more below). We further constructed 9 haploid (for non-essential genes) or heterozygous (for essential genes) deletion mutants to validate the observation from the bar-seq screens of the deletion libraries. We validated the observations in 7 out of 9 mutants, including one resistant and one sensitive mutant from the non-essential deletion pool, and 5 resistant mutants from essential heterozygous diploid pool (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S7</xref>). Among them, we validated the observed thiolutin resistance conferred by three strains heterozygous for deletions in proteasome subunit genes (<italic toggle="yes">PRE10/pre10&#x00394;</italic>, <italic toggle="yes">PUP1/pup1&#x00394;</italic>, <italic toggle="yes">RPN5/rpn5&#x00394;</italic>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S7</xref>).</p><p>The reconstructed strains validated the surprising but clear observation that heterozygous deletion mutants in proteasome subunit genes universally conferred thiolutin resistance (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S7</xref>). This is surprising because thiolutin was recently demonstrated to be a proteasome inhibitor through Zn<sup>2+</sup> chelation, and heterozygous proteasome subunit deletion mutants presumably may lead to reduced proteasome activity and would be expected to confer sensitivity to proteasome inhibitors. Interestingly, two recent reports observed similar paradoxical resistance to proteasome inhibitors in yeast strains and human cell lines with decreased level of the regulatory 19S proteasome subunits (<xref rid="B76" ref-type="bibr">76</xref>,<xref rid="B77" ref-type="bibr">77</xref>). In yeast and human, the fully assembled 26S proteasome consists of a 20S catalytic core and a 19S regulatory complex. It was demonstrated that decrease or transient inhibition of 19S proteasome subunits may in turn induce the level and activity of partially assembled 20S proteasome instead of the fully assembled 26S proteasome (<xref rid="B77" ref-type="bibr">77</xref>), resulting in a net increase of proteasome function. It was also recently suggested that specific reduced expression of 19S proteasome subunits induced an altered cellular state and altered the global transcriptome in response to proteasome inhibitors (<xref rid="B78" ref-type="bibr">78</xref>). However, our observation is distinct, because we observed decreases in both 19S and 20S proteasome subunits conferred thiolutin resistance. Whether the proteasome has increased level and activity in these strains has yet to be tested.</p></sec><sec id="SEC3-6"><title>Thiolutin alters divalent metal homeostasis</title><p>The recent detection of direct Zn<sup>2+</sup> chelation activity of reduced thiolutin and holomycin explains multiple thiolutin-induced phenotypes, such as inhibition of proteasome and glucose metabolism (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>). From the high-throughput screens, we observed distinct thiolutin resistance or sensitivity linked to diverse Zn<sup>2+</sup> trafficking genes, including those encoding the master transcription regulator Zap1 and various Zn<sup>2+</sup> transporters Zrt1, Zrt2, Zrc1 and Cot1 (Figure <xref rid="F2" ref-type="fig">2B</xref>). Variomics strains linked to <italic toggle="yes">ZAP1, ZRT1, ZRT2, ZRC1</italic> and <italic toggle="yes">COT1</italic> conferred thiolutin resistance whereas deletion mutants were either not resistant (<italic toggle="yes">zrt1&#x00394;</italic>, <italic toggle="yes">zrc1&#x00394;</italic>, <italic toggle="yes">cot1&#x00394;</italic>) or hypersensitive (<italic toggle="yes">zap1&#x00394;</italic> and <italic toggle="yes">zrt2&#x00394;</italic>) (Figure <xref rid="F2" ref-type="fig">2B</xref>), suggesting that these Variomics mutants could be gain-of-function or dosage modifiers of thiolutin resistance.</p><p>We first constructed a <italic toggle="yes">zap1&#x00394;</italic> strain and tested its sensitivity to thiolutin (Figure <xref rid="F3" ref-type="fig">3A</xref>). <italic toggle="yes">zap1&#x00394;</italic> confers hypersensitivity to thiolutin, consistent with Zap1 function in cellular resistance to thiolutin and thiolutin alteration of Zn<sup>2+</sup> homeostasis <italic toggle="yes">in vivo</italic>. Notably, <italic toggle="yes">zap1&#x00394;</italic> also conferred hypersensitivity to holomycin (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S8A</xref>). This observation is consistent with the reports that altering zinc homeostasis is a conserved mechanism among dithiolopyrrolones, and that holomycin could deplete cellular Zn<sup>2+</sup> or access other essential targets in yeast if zinc homeostasis were otherwise perturbed, and suggesting that yeast resistance to holomycin may be partially explained by efficient transportation of Zn<sup>2+</sup> that counteracts holomycin. <italic toggle="yes">zap1&#x00394;</italic> hyper-sensitivity to thiolutin and holomycin was much stronger than that to H<sub>2</sub>O<sub>2</sub>, suggesting the <italic toggle="yes">zap1&#x00394;</italic> hypersensitivity to thiolutin and holomycin were distinct from general oxidative stress exacerbation by zinc deficiency (<xref rid="B79" ref-type="bibr">79&#x02013;82</xref>). and likely to Zn<sup>2+</sup> homeostasis defects. Finally, Zn<sup>2+</sup> supplementation at high concentration partially suppressed thiolutin inhibition (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S8C</xref>). The lack of full suppression suggests that there may be other thiolutin-mediated defects in addition to Zn<sup>2+</sup> chelation, although we cannot rule out that inefficient Zn<sup>2+</sup> trafficking limits effective Zn<sup>2+</sup> supplementation in the cell.</p><p>In addition to Zn<sup>2+</sup> homeostasis mutants, we observed genes involved in Mn<sup>2+</sup> trafficking (<italic toggle="yes">PMR1, CCC2, VPS17, VPS25, SMF2</italic>) linked to thiolutin resistance (Figure <xref rid="F2" ref-type="fig">2B</xref>). Interestingly, <italic toggle="yes">PMR1</italic> is a high affinity Ca<sup>2+</sup> and Mn<sup>2+</sup> ATPase that is required for Ca<sup>2+</sup> and Mn<sup>2+</sup> transport to Golgi and subsequent export (<xref rid="B83" ref-type="bibr">83</xref>,<xref rid="B84" ref-type="bibr">84</xref>). <italic toggle="yes">pmr1&#x00394;</italic> has been shown to increase intracellular Mn<sup>2+</sup> level and appeared to confer thiolutin sensitivity (Figure <xref rid="F2" ref-type="fig">2B</xref>), which we confirmed by reconstructing a&#x000a0;<italic toggle="yes">pmr1&#x00394;</italic> mutant and plate phenotyping (Figure <xref rid="F3" ref-type="fig">3B</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S9A</xref>). In contrast, deletion of <italic toggle="yes">SMF2</italic>, a transporter for importing divalent metals including Mn<sup>2+</sup>, has been shown to cause intracellular Mn<sup>2+</sup> depletion and conferred slight but consistent thiolutin resistance (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S8A</xref>). Together, the intracellular level of Mn<sup>2+</sup> appeared to be positively correlated with thiolutin hypersensitivity, suggesting a mechanism distinct from Zn<sup>2+</sup>, where Zn<sup>2+</sup> supplementation confers partial thiolutin resistance (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S8C</xref>). To rule out the possibility that this altered thiolutin sensitivity is due to indirect effect from interference of other divalent metals, we phenotyped wild-type yeast strain in the presence of thiolutin and Mn<sup>2+</sup> supplementation. Indeed, we observed that Mn<sup>2+</sup> dose dependently exacerbated thiolutin sensitivity in wild-type yeast, supporting the synergy between Mn<sup>2+</sup> and thiolutin <italic toggle="yes">in vivo</italic> (Figure <xref rid="F3" ref-type="fig">3C</xref>).</p><p>In addition to <italic toggle="yes">pmr1&#x00394;</italic>, we also confirmed the thiolutin hypersensitivity of <italic toggle="yes">vps17&#x00394;</italic> and <italic toggle="yes">vps25&#x00394;</italic> (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S9A</xref>). Vps17 and Vps25 are two vacuolar protein sorting genes and have been implicated in degradation of the Mn<sup>2+</sup>-importing protein Smf1, thus possibly causing intracellular accumulation of Mn<sup>2+</sup> and conferring thiolutin hypersensitivity. However, <italic toggle="yes">vps17&#x00394;</italic> and <italic toggle="yes">vps25&#x00394;</italic> were not more sensitive to Mn<sup>2+</sup> than WT in our strain background (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S9B</xref>) and we found that <italic toggle="yes">smf1&#x00394;</italic> did not suppress the hypersensitivity conferred by <italic toggle="yes">vps17&#x00394;</italic> or <italic toggle="yes">vps25&#x00394;</italic> (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S9A</xref>), suggesting that other mechanisms may be involved in these two Vps mutants.</p><p>Given the contrasting Zn<sup>2+</sup> and apparent Mn<sup>2+</sup> modulation of thiolutin activity, and that metal homeostasis is complex with cross-talk between metals, we examined the intersection between divalent cations (Cd<sup>2+</sup>, Co<sup>2+</sup>, Cu<sup>2+</sup>, and Mg<sup>2+</sup> to compare with Mn<sup>2+</sup>), thiolutin, and thiolutin-sensitive deletions (<italic toggle="yes">zap1&#x00394;</italic>, <italic toggle="yes">pmr1&#x00394;</italic>, and <italic toggle="yes">sod1&#x00394;</italic>). We also compared thiolutin with 1,10-phenanthroline (1,10-pt), a chemically distinct Zn<sup>2+</sup> chelator that can inhibit yeast transcription <italic toggle="yes">in vivo</italic> (<xref rid="B85" ref-type="bibr">85&#x02013;87</xref>) (Figure <xref rid="F3" ref-type="fig">3D</xref>). Co<sup>2+</sup>, Cu<sup>2+</sup>, and Mn<sup>2+</sup> sensitized yeast to thiolutin specifically but not to 1,10-pt. The tested deletion strains appeared more sensitive to thiolutin than to 1,10-pt at the concentrations tested. 1,10-pt sensitivity was highest for <italic toggle="yes">zap1&#x00394;</italic>, consistent with 1,10-pt function as a Zn<sup>2+</sup> chelator. We also observed distinct effects of different 1,10-pt levels and suppression of <italic toggle="yes">sod1&#x00394;</italic> sensitivity to 40 &#x003bc;M 1,10-pt by Cu<sup>2+</sup> and Mn<sup>2+</sup>. These results suggest that thiolutin and 1,10-pt are distinct, especially in relationships to metals other than Zn<sup>2+</sup>.</p><p>We tested whether reduced thiolutin chelates Mn<sup>2+</sup> and Cu<sup>2+</sup>, while also confirming Zn<sup>2+</sup> chelation. Consistent with two recent reports (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>), Zn<sup>2+</sup> caused a distinct UV shift of reduced thiolutin from &#x0223c;340&#x000a0;to &#x0223c;370 nm but did not change the UV spectra of non-reduced thiolutin (Figure <xref rid="F3" ref-type="fig">3E</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S9C</xref>). In addition, we found that Mn<sup>2+</sup> and Cu<sup>2+</sup> can also interact with reduced but not non-reduced thiolutin, in a manner likely similar to Zn<sup>2+</sup> binding (Figure <xref rid="F3" ref-type="fig">3E</xref>). Consistently, 1H-NMR experiments confirmed that DTT caused chemical shifts consistent with reduction of the ene-disulfide in thiolutin, and further chemical shifts caused by diamagnetic Zn<sup>2+</sup> and selective broadening caused by paramagnetic Mn<sup>2+</sup> were consistent with interactions between the divalent metals and the thiolutin sulfhydryls (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S9D and E</xref>). In contrast, Mg<sup>2+</sup> did not bind to reduced thiolutin, distinct from the other tested metals (Figure <xref rid="F3" ref-type="fig">3E</xref>).</p></sec><sec id="SEC3-7"><title>Thiolutin, when activated by DTT and Mn<sup>2+</sup>, directly inhibits Pol II <italic toggle="yes">in vitro</italic></title><p>Despite the progress in understanding thiolutin induced cellular phenotypes, whether and how thiolutin directly inhibits yeast Pol II <italic toggle="yes">in vitro</italic> remained unresolved. Multiple lines of evidence suggest possible involvement of divalent metals in this process. First, the co-clustering of thiolutin and bathophenanthroline induced phenotypic profiles suggests similar modes of action (Figure <xref rid="F2" ref-type="fig">2C</xref>). Bathophenanthroline is highly similar to 1,10-pt (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S10</xref>), which was suggested to require Cu<sup>2+</sup> for direct transcription inhibition <italic toggle="yes">in vitro</italic> (<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B88" ref-type="bibr">88</xref>), though these compounds may have similar activities because they are also well-known Zn<sup>2+</sup> chelators (<xref rid="B89" ref-type="bibr">89</xref>). Second, the direct interaction between reduced thiolutin and divalent metals (Zn<sup>2+</sup>, Mn<sup>2+</sup> or Cu<sup>2+</sup>) suggests the possibility that thiolutin may function with multiple metal co-factors.</p><p>Many divalent metals inhibit RNAP activity (e.g. Pb<sup>2+</sup>, Zn<sup>2+</sup>, Cu<sup>2+</sup>, Be<sup>2+</sup>, Cd<sup>2+</sup>, Ca<sup>2+</sup>) (<xref rid="B90" ref-type="bibr">90</xref>), and additionally are tightly controlled in cells due to toxicity (<italic toggle="yes">e.g</italic>. Fe<sup>2+</sup>, Co<sup>2+</sup>), so may not participate in possible Pol II inhibition by thiolutin. Mn<sup>2+</sup> does not inhibit RNAP but instead increases the activity of multiple RNA polymerases (including Pol II) (<xref rid="B90" ref-type="bibr">90</xref>). In addition, Mn<sup>2+</sup> is readily available in yeast cells (0.04&#x02013;2&#x000a0;mM depending on the type of measurement while genetically shown to be at levels that likely can alter Pol II activity <italic toggle="yes">in vivo</italic>) (<xref rid="B91" ref-type="bibr">91&#x02013;95</xref>) at a relevant range to the reported thiolutin inhibitory concentration (&#x0223c;20&#x000a0;&#x003bc;M in (<xref rid="B20" ref-type="bibr">20</xref>)). We note that in the original Tipper observations (<xref rid="B20" ref-type="bibr">20</xref>), their transcription buffer contained 1.6 mM Mn<sup>2+</sup> as many classical transcription buffers included both Mn<sup>2+</sup> and Mg<sup>2+</sup> to maximize observed activity. In contrast, most other studies did not report Mn<sup>2+</sup> in buffers (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>) (One report appears to have a high concentration Mn<sup>2+</sup> (10 mM) and possibly also reductant (<xref rid="B19" ref-type="bibr">19</xref>)). Therefore, we set out to test whether Mn<sup>2+</sup> might participate in thiolutin-mediated inhibition of Pol II. Remarkably, Mn<sup>2+</sup> addition to reduced thiolutin potently inhibited purified Pol II activity (Figure <xref rid="F4" ref-type="fig">4A</xref>), in sharp contrast to the activation of Pol II activity caused by Mn<sup>2+</sup> by itself in the absence of reduced thiolutin. Our observation is consistent with the known stimulation of RNAPs by Mn<sup>2+</sup> (<xref rid="B90" ref-type="bibr">90</xref>,<xref rid="B96" ref-type="bibr">96</xref>), but also suggests a potent Pol II inhibition by Mn<sup>2+</sup> activated reduced thiolutin (hereafter termed as Thio/Mn<sup>2+</sup>) (Figure <xref rid="F4" ref-type="fig">4A</xref>, Quantification of thiolutin treatments and controls in Figure <xref rid="F4" ref-type="fig">4C</xref>,&#x000a0;D).</p><p>We next designed a series of experiments to investigate properties of the inhibited Pol II and nature of the inhibitory species. We first tested if order-of-addition among Pol II, DNA and Thio/Mn<sup>2+</sup> was critical for the inhibition, since order-of-addition is often informative on the mode of transcription inhibition (Figure <xref rid="F4" ref-type="fig">4B</xref>, <xref rid="F4" ref-type="fig">E</xref>). This is especially important given the observation of Tipper that order-of-addition was critical for thiolutin inhibition in that study (<xref rid="B20" ref-type="bibr">20</xref>). Consistent with the early observation, we found that the template binding protects Pol II from Thio/Mn<sup>2+</sup> inhibition (Figure <xref rid="F4" ref-type="fig">4B</xref>). Template protection of Pol II suggests Thio/Mn<sup>2+</sup> inhibits Pol II DNA interaction or similarly early step in transcription, consistent with the behavior of a&#x000a0;transcription initiation inhibitor. Therefore, we tested if Thio/Mn<sup>2+</sup> affected Pol II elongation on a transcription bubble template using an RNA primer, where transcription initiation is bypassed (Figure <xref rid="F4" ref-type="fig">4E</xref>). Surprisingly, Thio/Mn<sup>2+</sup> altered, but did not block Pol II transcription elongation, inducing a highly pause prone Pol II elongation mode (Figure <xref rid="F4" ref-type="fig">4E</xref>). This was unexpected because most specific initiation inhibitors do not cause elongation defects, and DNA binding does not protect RNAPs from elongation inhibitors by their very nature. In addition, pre-assembled transcription elongation complexes were also resistant to Thio/Mn<sup>2+</sup> (Figure <xref rid="F4" ref-type="fig">4E</xref>, bottom middle panel), validating the critical order-of-addition in the non-specific transcription assay (Figure <xref rid="F4" ref-type="fig">4B</xref>). Thio/Mn<sup>2+</sup> inhibited Pol II was pause-prone and appeared to irreversibly arrest at specific template positions (Figure <xref rid="F4" ref-type="fig">4E</xref>, bottom right panel).</p><p>Whether thiolutin inhibits transcription initiation or elongation <italic toggle="yes">in vivo</italic> is unclear (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B21" ref-type="bibr">21</xref>). In light of our <italic toggle="yes">in vitro</italic> results, we tested thiolutin-mediated Pol II transcription inhibition <italic toggle="yes">in vivo</italic>, first by monitoring Pol II occupancy on a long gene, <italic toggle="yes">YLR454W</italic> driven by the <italic toggle="yes">TEF1</italic> promoter, and then by Pol II ChIP-seq genome wide (Figure <xref rid="F5" ref-type="fig">5</xref>). We observed a specific decrease of Pol II occupancy by qPCR on the 5&#x02032; end of <italic toggle="yes">YLR454W</italic> within the first 2 min of thiolutin treatment, consistent with fast transcription initiation inhibition after thiolutin treatment (Figure <xref rid="F5" ref-type="fig">5</xref>). After 2 min, we also observed a relatively slower loss of Pol II from the template compared to previous experiments where transcription initiation was inhibited by other means, specifically by glucose shutoff or by carbon starvation of transcription from a <italic toggle="yes">GAL1</italic> promoter driven <italic toggle="yes">YLR454W</italic> reporter (<xref rid="B39" ref-type="bibr">39</xref>) (comparison with prior studies shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S11</xref>). Additionally, this decrease in Pol II occupancy at later time points does not fully cover the 3&#x02032; end as it does at <italic toggle="yes">GAL1p::YLR454W</italic> under the aforementioned inhibition conditions where the gene is clear of Pol II by 4&#x02013;6 min (<xref rid="B39" ref-type="bibr">39</xref>). These results suggest that thiolutin may have additional non-immediate inhibitory effects on Pol II elongation <italic toggle="yes">in vivo</italic> and that thiolutin treatment is not functioning solely through altering cellular signaling (e.g. through inhibition of the Tor pathway (<xref rid="B8" ref-type="bibr">8</xref>)) (Figure <xref rid="F5" ref-type="fig">5A</xref>). To assess kinetics of effects on Pol II occupancy in response to thiolutin treatment genome wide, we performed ChIP-seq for a FLAG-tagged Rpb3 Pol II component in triplicate upon thiolutin treatment (1, 2, 4, 8 min), DMSO vehicle treatment (8 min), or control cells (Figure <xref rid="F5" ref-type="fig">5B</xref>-<xref rid="F5" ref-type="fig">D</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S12</xref>). Our ChIP-seq protocol includes spike-in of Rpb3-FLAG chromatin from <italic toggle="yes">S. pombe</italic> allowing for determination of global effects (Figure <xref rid="F5" ref-type="fig">5B</xref>). Our experiments showed good reproducibility across replicates (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S12A,B</xref>)&#x000a0;with a clear trend of increased effects over time of thiolutin inhibition. We find evidence of broad decrease in Pol II occupancy genome wide (Figure <xref rid="F5" ref-type="fig">5C</xref>). We observe a continuum of effects for highly expressed genes where ribosomal protein (RP) genes are affected more strongly, then ribosome biogenesis genes (RiBi), then other genes (Figure <xref rid="F5" ref-type="fig">5D</xref>, <xref rid="F5" ref-type="fig">E</xref>). These results are consistent with reported inhibition of the Tor pathway upon thiolutin treatment but there also more widespread, but muted decreases in Pol II occupancy. Consistent with our observation at <italic toggle="yes">TEF1p::YLR454W</italic>, metaplots for all genes in the top 40% of Pol II occupancy&#x000a0;&#x02265;&#x000a0;1.5kb in length show an initial decrease in Pol II occupancy at the 5&#x02032; end upon thiolutin treatment (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S12C</xref>). The most striking effects of thiolutin on Pol II occupancy are those that occur with rapid kinetics, e.g. decreased occupancy on highly expressed genes, specifically of the RP and RiBi classes, and rapid increased occupancy of a small subset of genes. These classes of effect like involve in Tor signaling inhibition (<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B30" ref-type="bibr">30</xref>,<xref rid="B97" ref-type="bibr">97</xref>) and stress response activation (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B85" ref-type="bibr">85</xref>), respectively. The more muted but widespread effects and potential slowing of elongation could be consistent with additional, direct or indirect effects of thiolutin that occur with reduced kinetics (see Discussion).</p><p>To investigate the nature of the inhibitory species, we further examined thiolutin interaction with Mn<sup>2+</sup>. Interestingly, we observed continuous and reproducible changes of the UV spectra after Mn<sup>2+</sup> was added to reduced thiolutin (Figure <xref rid="F6" ref-type="fig">6A</xref>), suggesting changing chemical species in the reaction. The peak of UV absorbance was shifted from 340&#x000a0;nm (reduced thiolutin) to around 380&#x000a0;nm in the first two min, with subsequent decrease in the 380&#x000a0;nm peak as a third species at 300&#x000a0;nm started to accumulate (Figure <xref rid="F6" ref-type="fig">6A</xref>). The reaction reached a relative stable equilibrium after 20 min. Our data revealed the dynamic change and two major species after Mn<sup>2+</sup> addition to reduced thiolutin but could not distinguish how either of these related to the inhibitory species. To test this question, we prepared Thio/Mn<sup>2+</sup> and either freshly treated Pol II or incubated at room temperature for 20 min before treating Pol II (Figure <xref rid="F6" ref-type="fig">6B</xref>). Remarkably, we observed strong Pol II inhibition by freshly prepared Thio/Mn<sup>2+</sup> but complete loss of Thio/Mn<sup>2+</sup> inhibitory activity after 20 min (Figure <xref rid="F6" ref-type="fig">6B</xref>). This result is consistent with the 380&#x000a0;nm species possibly contributing to Pol II inhibition yet being unstable in solution. In contrast to the window for inhibitory activity of Thio/Mn<sup>2+</sup>, immediately treated Pol II was inhibited for up to 50 min (20-min&#x000a0;incubation and 30-min&#x000a0;reaction time), suggesting that the Pol II inhibition was stable (Figure <xref rid="F6" ref-type="fig">6B</xref>).</p><fig position="float" id="F6"><label>Figure 6.</label><caption><p>The apparent thiolutin/Mn<sup>2+</sup> complex is unstable in solution but Pol II can be&#x000a0;stably altered. (<bold>A</bold>) Time course of changing UV spectra of reduced thiolutin treated with Mn<sup>2+</sup>. Reduced thiolutin (blue, 0 min) was treated with equivalent molar Mn<sup>2+</sup>, and the UV spectra were&#x000a0;acquired at different time points. Spectra over time were&#x000a0;colored in a color gradient from blue to red. Three experimental replicates were performed, and a representative replicate is shown. (<bold>B</bold>) Thio/Mn<sup>2+</sup> lost inhibitory activity after 20 min&#x000a0;in solution though immediately treated Pol II remains inhibited. Two experimental replicates were performed and were&#x000a0;consistent. One replicate is shown. (<bold>C</bold>) Thio/Mn<sup>2+</sup> can be reversed by excess DTT. Excess of DTT was added after 20 min of Pol II inhibition by Thio/Mn<sup>2+</sup>. DTT was at 12 mM during thiolutin treatment. Two replicates under these exact conditions were performed, and a representative replicate is shown. Results are representative of additional experiments performed under slightly different conditions.</p></caption><graphic xlink:href="gkad1258fig6" position="float"/></fig><p>We propose two models to reconcile the observation that Pol II stabilized the unstable 380nm inhibitory species. First, Pol II might stabilize the inhibitory species in a tight pocket that prevented further reaction into other inactive species. Second, Mn<sup>2+</sup> might coordinate with reduced thiolutin to form a disulfide bond within Pol II or possibly a thiolutin adduct, as Cu<sup>2+</sup> does to facilitate disulfide formation through cysteine sulfenylation in other proteins (<xref rid="B98" ref-type="bibr">98&#x02013;100</xref>). If sulfenylation and disulfide bond formation were involved, the Thio/Mn<sup>2+</sup> inhibition is expected to be suppressible by a high concentration of DTT. Indeed, we found that excess DTT abolished the inhibition, consistent with the involvement of reductant sensitive inhibition (Figure <xref rid="F6" ref-type="fig">6C</xref>).</p></sec></sec><sec sec-type="discussion" id="SEC4"><title>Discussion</title><p>Thiolutin is a well-known transcription inhibitor that has been used in mRNA stability studies, but its mode of inhibition has been complicated and unresolved. It has been demonstrated that reduced thiolutin and the related natural product holomycin chelate Zn<sup>2+</sup><italic toggle="yes">in vitro</italic>, and thiolutin chelation of Zn<sup>2+</sup> could specifically inhibit diverse classes of metalloproteins (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>). However, these previous reports failed to observe direct thiolutin inhibition of RNAPs, under conditions where Zn<sup>2+</sup> chelation was permissible. Here we present three independent genetic screens for thiolutin resistant or sensitive mutants, providing a genetic basis for understanding thiolutin-altered cellular responses and reveal a direct mode of action against Pol II <italic toggle="yes">in vivo</italic>. We show that alterations in diverse cellular pathways can modulate cellular sensitivity to thiolutin. In light of our genetic results, we discovered that both reductant DTT and Mn<sup>2+</sup> together activate thiolutin for direct inhibition of Pol II function, countering the recent narrative while confirming classic observations (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B20" ref-type="bibr">20</xref>).</p><sec id="SEC4-1"><title>Thiolutin inhibits Pol II through a novel mode of action</title><p>We propose that Thio/Mn<sup>2+</sup> inhibits Pol II through a novel mode of action. The critical order of treating Pol II with thiolutin prior to template DNA binding is a stereotypical behavior for RNAP clamp inhibitors (<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B101" ref-type="bibr">101&#x02013;104</xref>), which are distinct from inhibitors targeting the active site, NTP uptake, or RNA exit channels. In addition, we show that thiolutin inhibits Pol II elongation on an initiation-bypassing transcription bubble template, distinct from all the three characterized <italic toggle="yes">E. coli</italic> RNAP inhibitors that lock the clamp in the closed state (Myxopronin (Myx), Corallopyronin (Cor)&#x000a0;and Ripostatin (Rip)) that do not inhibit RNAP elongation (<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B105" ref-type="bibr">105</xref>). It should be noted that Lipiarmycin (Lpm), an inhibitor that appears to lock the clamp in the partially or fully open state (<xref rid="B24" ref-type="bibr">24</xref>), has never been tested on a bubble template. Therefore, thiolutin behaves differently from Myx, Cor and Rip, but further experiments are in need to test whether thiolutin behaves similarly to Lpm. Finally, the exact thiolutin binding site on Pol II remains unclear, and our data cannot rule out the possibility that thiolutin may inhibit Pol II regions other than clamp-controlling switch regions.</p></sec><sec id="SEC4-2"><title>Diverse cellular pathways modulate thiolutin multiple modes of action</title><p>Our genetic screens reveal the contribution of diverse cellular pathways in thiolutin sensitivity. Many of these pathways can be reconciled in a unified model based on current understanding of thiolutin's modes of action. In the cell, the thiolutin intra-molecular disulfide bond appears to be reduced, and we propose thioredoxins Trx1 and Trx2 directly or indirectly contribute to thiolutin reduction (along with glutathione) or are responsive to thiolutin oxidation of other proteins, thereby promoting thioredoxin oxidation. Reduced thiolutin subsequently chelates Zn<sup>2+</sup> to inhibit multiple metalloproteins (e.g. Rpn11 and conferring block to proteasomal degradation of substrates), affects Zn<sup>2+</sup> homeostasis, interacts with Mn<sup>2+</sup> to inhibit Pol II transcription (and possibly Pol I and III), or become re-oxidized by molecular oxygen. Mn<sup>2+</sup>, Co<sup>2+</sup>&#x000a0;and Cu<sup>2+</sup> also sensitize cells to thiolutin treatment while 1,10-pt does not, suggesting these interactions may not be caused by Zn<sup>2+</sup> starvation. The reduction or redox cycling of thiolutin may induce the observed Yap1 nuclear localization and oxidative stresses. In addition, we have shown that reduced thiolutin may also chelate other divalent metals such as Cu<sup>2+</sup> (but not Mg<sup>2+</sup>), but whether other thiolutin-metal complexes have additional activities remains to be further tested.</p></sec><sec id="SEC4-3"><title>Thiolutin should not be used as a tool for transcription inhibition <italic toggle="yes">in vivo</italic></title><p>Our work underpins the caveats for using thiolutin as a transcription inhibitor to investigate other cellular processes, as suggested by previous studies (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>). As a routinely used transcription inhibitor to study mRNA stability, it was shown that thiolutin itself inhibits mRNA degradation and complicates the quantitation of mRNA half-life at higher doses (<xref rid="B9" ref-type="bibr">9</xref>). The rapid kinetics of Pol II occupancy changes we observe for RP genes are consistent with a potential immediate perturbation to Tor signaling. Note that a previous study only examined Tor pathway response at 10 min of thiolutin or 1,10-pt treatment, whereas our work suggests potential effects would be nearly immediate. RiBi genes are also downstream of the Tor pathway (<xref rid="B30" ref-type="bibr">30</xref>,<xref rid="B97" ref-type="bibr">97</xref>) are strongly affected for Pol II occupancy. However, most other genes of similar expression level to RiBi show similar decreases in Pol II occupancy (Figure <xref rid="F5" ref-type="fig">5E</xref>). Net decreases in occupancy are widespread (Figure <xref rid="F5" ref-type="fig">5D</xref>, <xref rid="F5" ref-type="fig">E</xref>) but a small subset of genes is activated by thiolutin treatment with rapid kinetics (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S12B</xref>). Activation of this subset is consistent with an immediate stress response that precedes any potentially slower, direct effects of thiolutin (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B85" ref-type="bibr">85</xref>,<xref rid="B106" ref-type="bibr">106</xref>). Our observation that elongation of a long reporter gene, <italic toggle="yes">TEF1p::YLR454W</italic>, appears slow upon thiolutin inhibition of initiation is striking and points to effects that require careful dissection in future experiments. Our work here and prior work discussed above suggest that thiolutin is multifunctional and has pleiotropic effects.</p></sec><sec id="SEC4-4"><title>Thiolutin mode of action may reveal insights into Pol II pausing</title><p>The thiolutin induced pause (and arrest) pattern <italic toggle="yes">in vitro</italic> appears to be highly specific and position-dependent, and it will be interesting to further investigate the pause sequence preference and its possible connection to a specific inhibited Pol II conformation. As discussed above, biochemical properties of thiolutin inhibited Pol II most closely resembles clamp inhibition by a locked non-closed state, possibly a partially or fully open state. It is tempting to hypothesize that the thiolutin-induced pause prone Pol II is linked to a specific Pol II conformation. This hypothesis is also consistent with the observations in <italic toggle="yes">E. coli</italic> RNAP that paused elongation complexes appear to correlate with open clamp and TL states, which can be reversed and possibly regulated by elongation factor RfaH (<xref rid="B107" ref-type="bibr">107</xref>,<xref rid="B108" ref-type="bibr">108</xref>). It has been proposed that this RfaH (a homolog of Spt5 in eukaryotes) pause suppression through the RNAP clamp may be a conserved regulatory mechanism for RNAP elongation in all domains of life (<xref rid="B109" ref-type="bibr">109</xref>). Further characterization of thiolutin inhibited Pol II may reveal additional insights into this process in eukaryotes.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sup1" position="float" content-type="local-data"><label>gkad1258_Supplemental_Files</label><media xlink:href="gkad1258_supplemental_files.zip"/></supplementary-material></sec></body><back><ack id="ACK1"><title>Acknowledgements</title><p>We thank Xuewen Pan for the kind gift of Variomics libraries, and Guillermo Calero for one of the Pol II purifications used here. We thank Alex Francette and Karen Arndt for the gift of <italic toggle="yes">S. pombe</italic> chromatin and for advice and sharing of scripts for ChIP-seq analyses. We thank Allyson O&#x02019;Donnell for advice on analysis of <italic toggle="yes">YAP1-GFP</italic> imaging and data analysis.</p></ack><sec sec-type="data-availability" id="SEC5"><title>Data availability</title><p>Sequencing data are available at the Sequence Read Archive under Bioproject. Scripts for data analysis are found at <ext-link xlink:href="https://github.com/Kaplan-Lab-Pitt/Thiolutin" ext-link-type="uri">https://github.com/Kaplan-Lab-Pitt/Thiolutin</ext-link>&#x000a0;and <ext-link xlink:href="https://zenodo.org/doi/10.5281/zenodo.10428579" ext-link-type="uri">https://zenodo.org/doi/10.5281/zenodo.10428579</ext-link>.</p></sec><sec id="SEC6"><title>Supplementary data</title><p>
<ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkad1258#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p></sec><sec id="SEC7"><title>Funding</title><p>National Institutes of Health (NIH) [R01GM097260, R35GM144116 to C.D.K.]; Welch Foundation Grant [A-1763 to C.D.K.] for support on this project while our lab was at Texas A&#x00026;M University; National Science Foundation for funding a Research Experience for Undergraduates [DBI-0851611 to Texas A&#x00026;M Department of Biochemistry and Biophysics for support of A.J.L., S.U., E.M.P.]. Funding for open access charge: NIH [R35GM144116].</p><p>
<italic toggle="yes">Conflict of interest statement</italic>. None declared.</p></sec><notes id="NT1"><title>Notes</title><p>Present address: Chenxi Qiu,&#x000a0;Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.</p><p>Present address: Indranil Malik,&#x000a0;Department of Biotechnology, Indian Institute of Technology Hyderabad, Sangareddy, Telangana, India.</p><p>Present address: Amber J. Laperuta,&#x000a0;Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15217, USA.</p><p>Present address: Emily M. Pavlovic,&#x000a0;University of Minnesota-Duluth, Duluth, MN 55812, USA.</p><p>Present address: Mandar Naik,&#x000a0;Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI 02912, USA.</p></notes><ref-list id="REF1"><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Walsh</surname> &#x000a0;<given-names>C.T.</given-names></string-name></person-group> &#x000a0;<article-title>Streptomyces clavuligerus HlmI is an intramolecular disulfide-forming dithiol oxidase in holomycin biosynthesis</article-title>. <source>Biochemistry</source>. <year>2011</year>; <volume>50</volume>:<fpage>4615</fpage>&#x02013;<lpage>4622</lpage>.<pub-id pub-id-type="pmid">21504228</pub-id>
</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Wever</surname> &#x000a0;<given-names>W.J.</given-names></string-name>, <string-name><surname>Walsh</surname> &#x000a0;<given-names>C.T.</given-names></string-name>, <string-name><surname>Bowers</surname> &#x000a0;<given-names>A.A.</given-names></string-name></person-group> &#x000a0;<article-title>Dithiolopyrrolones: biosynthesis, synthesis, and activity of a unique class of disulfide-containing antibiotics</article-title>. <source>Nat. Prod. Rep.</source> &#x000a0;<year>2014</year>; <volume>31</volume>:<fpage>905</fpage>&#x02013;<lpage>923</lpage>.<pub-id pub-id-type="pmid">24835149</pub-id>
</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Rossini</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Taylor</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Fagan</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Hastings</surname> &#x000a0;<given-names>J.W.</given-names></string-name></person-group> &#x000a0;<article-title>Lifetimes of mRNAs for clock-regulated proteins in a dinoflagellate</article-title>. <source>Chronobiol. Int.</source> &#x000a0;<year>2003</year>; <volume>20</volume>:<fpage>963</fpage>&#x02013;<lpage>976</lpage>.<pub-id pub-id-type="pmid">14680137</pub-id>
</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Grigull</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Mnaimneh</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Pootoolal</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Robinson</surname> &#x000a0;<given-names>M.D.</given-names></string-name>, <string-name><surname>Hughes</surname> &#x000a0;<given-names>T.R.</given-names></string-name></person-group> &#x000a0;<article-title>Genome-wide analysis of mRNA stability using transcription inhibitors and microarrays reveals posttranscriptional control of ribosome biogenesis factors</article-title>. <source>Mol. Cell. Biol.</source> &#x000a0;<year>2004</year>; <volume>24</volume>:<fpage>5534</fpage>&#x02013;<lpage>5547</lpage>.<pub-id pub-id-type="pmid">15169913</pub-id>
</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kebaara</surname> &#x000a0;<given-names>B.W.</given-names></string-name>, <string-name><surname>Nielsen</surname> &#x000a0;<given-names>L.E.</given-names></string-name>, <string-name><surname>Nickerson</surname> &#x000a0;<given-names>K.W.</given-names></string-name>, <string-name><surname>Atkin</surname> &#x000a0;<given-names>A.L.</given-names></string-name></person-group> &#x000a0;<article-title>Determination of mRNA half-lives in <italic toggle="yes">Candida albicans</italic> using thiolutin as a transcription inhibitor</article-title>. <source>Genome</source>. <year>2006</year>; <volume>49</volume>:<fpage>894</fpage>&#x02013;<lpage>899</lpage>.<pub-id pub-id-type="pmid">17036064</pub-id>
</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Morey</surname> &#x000a0;<given-names>J.S.</given-names></string-name>, <string-name><surname>Van&#x000a0;Dolah</surname> &#x000a0;<given-names>F.M.</given-names></string-name></person-group> &#x000a0;<article-title>Global analysis of mRNA half-lives and de novo transcription in a dinoflagellate, <italic toggle="yes">Karenia brevis</italic></article-title>. <source>PLoS One</source>. <year>2013</year>; <volume>8</volume>:<fpage>e66347</fpage>.<pub-id pub-id-type="pmid">23776661</pub-id>
</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bergmann</surname> &#x000a0;<given-names>R.</given-names></string-name>
</person-group> &#x000a0;<article-title>Thiolutin inhibits utilization of glucose and other carbon sources in cells of <italic toggle="yes">Escherichia coli</italic></article-title>. <source>Antonie Van Leeuwenhoek</source>. <year>1989</year>; <volume>55</volume>:<fpage>143</fpage>&#x02013;<lpage>152</lpage>.<pub-id pub-id-type="pmid">2662903</pub-id>
</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Eshleman</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Luo</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Capaldi</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Buchan</surname> &#x000a0;<given-names>J.R.</given-names></string-name></person-group> &#x000a0;<article-title>Alterations of signaling pathways in response to chemical perturbations used to measure mRNA decay rates in yeast</article-title>. <source>RNA</source>. <year>2020</year>; <volume>26</volume>:<fpage>10</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">31601735</pub-id>
</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pelechano</surname> &#x000a0;<given-names>V.</given-names></string-name>, <string-name><surname>Perez-Ortin</surname> &#x000a0;<given-names>J.E.</given-names></string-name></person-group> &#x000a0;<article-title>The transcriptional inhibitor thiolutin blocks mRNA degradation in yeast</article-title>. <source>Yeast</source>. <year>2008</year>; <volume>25</volume>:<fpage>85</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">17914747</pub-id>
</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Monje-Casas</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Michan</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Pueyo</surname> &#x000a0;<given-names>C.</given-names></string-name></person-group> &#x000a0;<article-title>Absolute transcript levels of thioredoxin- and glutathione-dependent redox systems in <italic toggle="yes">Saccharomyces cerevisiae</italic>: response to stress and modulation with growth</article-title>. <source>Biochem. J.</source> &#x000a0;<year>2004</year>; <volume>383</volume>:<fpage>139</fpage>&#x02013;<lpage>147</lpage>.<pub-id pub-id-type="pmid">15222878</pub-id>
</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lauinger</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Shostak</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Cemel</surname> &#x000a0;<given-names>I.A.</given-names></string-name>, <string-name><surname>Ha</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Merkl</surname> &#x000a0;<given-names>P.E.</given-names></string-name>, <string-name><surname>Obermeyer</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Stankovic-Valentin</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Schafmeier</surname> &#x000a0;<given-names>T.</given-names></string-name></person-group> &#x000a0;<article-title>Thiolutin is a zinc chelator that inhibits the Rpn11 and other JAMM metalloproteases</article-title>. <source>Nat. Chem. Biol.</source> &#x000a0;<year>2017</year>; <volume>13</volume>:<fpage>709</fpage>&#x02013;<lpage>714</lpage>.<pub-id pub-id-type="pmid">28459440</pub-id>
</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chan</surname> &#x000a0;<given-names>A.N.</given-names></string-name>, <string-name><surname>Shiver</surname> &#x000a0;<given-names>A.L.</given-names></string-name>, <string-name><surname>Wever</surname> &#x000a0;<given-names>W.J.</given-names></string-name>, <string-name><surname>Razvi</surname> &#x000a0;<given-names>S.Z.</given-names></string-name>, <string-name><surname>Traxler</surname> &#x000a0;<given-names>M.F.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>B.</given-names></string-name></person-group> &#x000a0;<article-title>Role for dithiolopyrrolones in disrupting bacterial metal homeostasis</article-title>. <source>Proc. Nat. Acad. Sci. U.S.A.</source> &#x000a0;<year>2017</year>; <volume>114</volume>:<fpage>2717</fpage>&#x02013;<lpage>2722</lpage>.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fuchs</surname> &#x000a0;<given-names>A.C.D.</given-names></string-name>, <string-name><surname>Maldoner</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Wojtynek</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Hartmann</surname> &#x000a0;<given-names>M.D.</given-names></string-name>, <string-name><surname>Martin</surname> &#x000a0;<given-names>J.</given-names></string-name></person-group> &#x000a0;<article-title>Rpn11-mediated ubiquitin processing in an ancestral archaeal ubiquitination system</article-title>. <source>Nat. Commun.</source> &#x000a0;<year>2018</year>; <volume>9</volume>:<fpage>2696</fpage>.<pub-id pub-id-type="pmid">30002364</pub-id>
</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Baell</surname> &#x000a0;<given-names>J.B.</given-names></string-name>
</person-group> &#x000a0;<article-title>Redox-active nuisance screening compounds and their classification</article-title>. <source>Drug Discovery Today</source>. <year>2011</year>; <volume>16</volume>:<fpage>840</fpage>&#x02013;<lpage>841</lpage>.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Johnston</surname> &#x000a0;<given-names>P.A.</given-names></string-name>
</person-group> &#x000a0;<article-title>Redox cycling compounds generate H2O2 in HTS buffers containing strong reducing reagents&#x02013;real hits or promiscuous artifacts</article-title>. <source>Curr. Opin. Chem. Biol.</source> &#x000a0;<year>2011</year>; <volume>15</volume>:<fpage>174</fpage>&#x02013;<lpage>182</lpage>.<pub-id pub-id-type="pmid">21075044</pub-id>
</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Albini</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Bormann</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Gerschel</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Ludwig</surname> &#x000a0;<given-names>V.A.</given-names></string-name>, <string-name><surname>Neumann</surname> &#x000a0;<given-names>W.</given-names></string-name></person-group> &#x000a0;<article-title>Dithiolopyrrolones are prochelators that are activated by glutathione</article-title>. <source>Chemistry</source>. <year>2023</year>; <volume>29</volume>:<fpage>e202202567</fpage>.<pub-id pub-id-type="pmid">36214647</pub-id>
</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Khachatourians</surname> &#x000a0;<given-names>G.G.</given-names></string-name>, <string-name><surname>Tipper</surname> &#x000a0;<given-names>D.J.</given-names></string-name></person-group> &#x000a0;<article-title>In vivo effect of thiolutin on cell growth and macromolecular synthesis in Escherichia coli</article-title>. <source>Antimicrob. Agents Chemother.</source> &#x000a0;<year>1974</year>; <volume>6</volume>:<fpage>304</fpage>&#x02013;<lpage>310</lpage>.<pub-id pub-id-type="pmid">15830477</pub-id>
</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Joshi</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Verma</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Chakravorty</surname> &#x000a0;<given-names>M.</given-names></string-name></person-group> &#x000a0;<article-title>Thiolutin-resistant mutants of <italic toggle="yes">Salmonella typhimurium</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> &#x000a0;<year>1982</year>; <volume>22</volume>:<fpage>541</fpage>&#x02013;<lpage>547</lpage>.<pub-id pub-id-type="pmid">6758684</pub-id>
</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Roza</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Blanco</surname> &#x000a0;<given-names>M.G.</given-names></string-name>, <string-name><surname>Hardisson</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Salas</surname> &#x000a0;<given-names>J.A.</given-names></string-name></person-group> &#x000a0;<article-title>Self-resistance in actinomycetes producing inhibitors of RNA polymerase</article-title>. <source>J. Antibiot. (Tokyo)</source>. <year>1986</year>; <volume>39</volume>:<fpage>609</fpage>&#x02013;<lpage>612</lpage>.<pub-id pub-id-type="pmid">3710921</pub-id>
</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tipper</surname> &#x000a0;<given-names>D.J.</given-names></string-name>
</person-group> &#x000a0;<article-title>Inhibition of yeast ribonucleic acid polymerases by thiolutin</article-title>. <source>J. Bacteriol.</source> &#x000a0;<year>1973</year>; <volume>116</volume>:<fpage>245</fpage>&#x02013;<lpage>256</lpage>.<pub-id pub-id-type="pmid">4583213</pub-id>
</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sivasubramanian</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Jayaraman</surname> &#x000a0;<given-names>R.</given-names></string-name></person-group> &#x000a0;<article-title>Thiolutin resistant mutants of <italic toggle="yes">Escherichia coli</italic> are they RNA chain initiation mutants</article-title>. <source>Mol. Gen. Genet.</source> &#x000a0;<year>1976</year>; <volume>145</volume>:<fpage>89</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">775314</pub-id>
</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Oliva</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>O&#x02019;Neill</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Wilson</surname> &#x000a0;<given-names>J.M.</given-names></string-name>, <string-name><surname>O&#x02019;Hanlon</surname> &#x000a0;<given-names>P.J.</given-names></string-name>, <string-name><surname>Chopra</surname> &#x000a0;<given-names>I.</given-names></string-name></person-group> &#x000a0;<article-title>Antimicrobial properties and mode of action of the pyrrothine holomycin</article-title>. <source>Antimicrob. Agents Chemother.</source> &#x000a0;<year>2001</year>; <volume>45</volume>:<fpage>532</fpage>&#x02013;<lpage>539</lpage>.<pub-id pub-id-type="pmid">11158751</pub-id>
</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mukhopadhyay</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Das</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Ismail</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Koppstein</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Jang</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Hudson</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Sarafianos</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Tuske</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Patel</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Jansen</surname> &#x000a0;<given-names>R.</given-names></string-name></person-group> &#x000a0;<article-title>The RNA polymerase &#x0201c;switch region&#x0201d; is a target for inhibitors</article-title>. <source>Cell</source>. <year>2008</year>; <volume>135</volume>:<fpage>295</fpage>&#x02013;<lpage>307</lpage>.<pub-id pub-id-type="pmid">18957204</pub-id>
</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname> &#x000a0;<given-names>D.</given-names></string-name>
</person-group> &#x000a0;<source>Ensemble Fluorescence Resonance Energy Transfer Analysis of RNA Polymerase Clamp Conformation</source>. <year>2008</year>; <publisher-name>Rutgers The State University of New Jersey-New Brunswick</publisher-name>.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Smith</surname> &#x000a0;<given-names>A.M.</given-names></string-name>, <string-name><surname>Heisler</surname> &#x000a0;<given-names>L.E.</given-names></string-name>, <string-name><surname>Mellor</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Kaper</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Thompson</surname> &#x000a0;<given-names>M.J.</given-names></string-name>, <string-name><surname>Chee</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Roth</surname> &#x000a0;<given-names>F.P.</given-names></string-name>, <string-name><surname>Giaever</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Nislow</surname> &#x000a0;<given-names>C.</given-names></string-name></person-group> &#x000a0;<article-title>Quantitative phenotyping via deep barcode sequencing</article-title>. <source>Genome Res.</source> &#x000a0;<year>2009</year>; <volume>19</volume>:<fpage>1836</fpage>&#x02013;<lpage>1842</lpage>.<pub-id pub-id-type="pmid">19622793</pub-id>
</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname> &#x000a0;<given-names>A.Y.</given-names></string-name>, <string-name><surname>St&#x000a0;Onge</surname> &#x000a0;<given-names>R.P.</given-names></string-name>, <string-name><surname>Proctor</surname> &#x000a0;<given-names>M.J.</given-names></string-name>, <string-name><surname>Wallace</surname> &#x000a0;<given-names>I.M.</given-names></string-name>, <string-name><surname>Nile</surname> &#x000a0;<given-names>A.H.</given-names></string-name>, <string-name><surname>Spagnuolo</surname> &#x000a0;<given-names>P.A.</given-names></string-name>, <string-name><surname>Jitkova</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Gronda</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Wu</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>M.K.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>Mapping the cellular response to small molecules using chemogenomic fitness signatures</article-title>. <source>Science</source>. <year>2014</year>; <volume>344</volume>:<fpage>208</fpage>&#x02013;<lpage>211</lpage>.<pub-id pub-id-type="pmid">24723613</pub-id>
</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Parsons</surname> &#x000a0;<given-names>A.B.</given-names></string-name>, <string-name><surname>Lopez</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Givoni</surname> &#x000a0;<given-names>I.E.</given-names></string-name>, <string-name><surname>Williams</surname> &#x000a0;<given-names>D.E.</given-names></string-name>, <string-name><surname>Gray</surname> &#x000a0;<given-names>C.A.</given-names></string-name>, <string-name><surname>Porter</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Chua</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Sopko</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Brost</surname> &#x000a0;<given-names>R.L.</given-names></string-name>, <string-name><surname>Ho</surname> &#x000a0;<given-names>C.H.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast</article-title>. <source>Cell</source>. <year>2006</year>; <volume>126</volume>:<fpage>611</fpage>&#x02013;<lpage>625</lpage>.<pub-id pub-id-type="pmid">16901791</pub-id>
</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Perrin</surname> &#x000a0;<given-names>D.M.</given-names></string-name>, <string-name><surname>Pearson</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Mazumder</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Sigman</surname> &#x000a0;<given-names>D.S.</given-names></string-name></person-group> &#x000a0;<article-title>Inhibition of prokaryotic and eukaryotic transcription by the 2:1 2,9-dimethyl-1,10-phenanthroline-cuprous complex, a ligand specific for open complexes</article-title>. <source>Gene</source>. <year>1994</year>; <volume>149</volume>:<fpage>173</fpage>&#x02013;<lpage>178</lpage>.<pub-id pub-id-type="pmid">7958982</pub-id>
</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Rohde</surname> &#x000a0;<given-names>J.R.</given-names></string-name>, <string-name><surname>Bastidas</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Puria</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Cardenas</surname> &#x000a0;<given-names>M.E.</given-names></string-name></person-group> &#x000a0;<article-title>Nutritional control via tor signaling in Saccharomyces cerevisiae</article-title>. <source>Curr. Opin. Microbiol.</source> &#x000a0;<year>2008</year>; <volume>11</volume>:<fpage>153</fpage>&#x02013;<lpage>160</lpage>.<pub-id pub-id-type="pmid">18396450</pub-id>
</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Shore</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Zencir</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Albert</surname> &#x000a0;<given-names>B.</given-names></string-name></person-group> &#x000a0;<article-title>Transcriptional control of ribosome biogenesis in yeast: links to growth and stress signals</article-title>. <source>Biochem. Soc. Trans.</source> &#x000a0;<year>2021</year>; <volume>49</volume>:<fpage>1589</fpage>&#x02013;<lpage>1599</lpage>.<pub-id pub-id-type="pmid">34240738</pub-id>
</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Janke</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Magiera</surname> &#x000a0;<given-names>M.M.</given-names></string-name>, <string-name><surname>Rathfelder</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Taxis</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Reber</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Maekawa</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Moreno-Borchart</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Doenges</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Schwob</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Schiebel</surname> &#x000a0;<given-names>E.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>A versatile toolbox for PCR-based tagging of yeast genes: new fluorescent proteins, more markers and promoter substitution cassettes</article-title>. <source>Yeast</source>. <year>2004</year>; <volume>21</volume>:<fpage>947</fpage>&#x02013;<lpage>962</lpage>.<pub-id pub-id-type="pmid">15334558</pub-id>
</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chee</surname> &#x000a0;<given-names>M.K.</given-names></string-name>, <string-name><surname>Haase</surname> &#x000a0;<given-names>S.B.</given-names></string-name></person-group> &#x000a0;<article-title>New and redesigned pRS plasmid shuttle vectors for genetic manipulation of saccharomyces cerevisiae</article-title>. <source>G3: Genes Genomes Genetics</source>. <year>2012</year>; <volume>2</volume>:<fpage>515</fpage>&#x02013;<lpage>526</lpage>.<pub-id pub-id-type="pmid">22670222</pub-id>
</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Huang</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Cui</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Tang</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Shi</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>W.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>A functional variomics tool for discovering drug-resistance genes and drug targets</article-title>. <source>Cell Rep.</source> &#x000a0;<year>2013</year>; <volume>3</volume>:<fpage>577</fpage>&#x02013;<lpage>585</lpage>.<pub-id pub-id-type="pmid">23416056</pub-id>
</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Langmead</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Salzberg</surname> &#x000a0;<given-names>S.L.</given-names></string-name></person-group> &#x000a0;<article-title>Fast gapped-read alignment with Bowtie 2</article-title>. <source>Nat. Methods</source>. <year>2012</year>; <volume>9</volume>:<fpage>357</fpage>&#x02013;<lpage>359</lpage>.<pub-id pub-id-type="pmid">22388286</pub-id>
</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Handsaker</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Wysoker</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Fennell</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Ruan</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Homer</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Marth</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Abecasis</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Durbin</surname> &#x000a0;<given-names>R.</given-names></string-name><collab>Genome Project Data Processing, S</collab></person-group> &#x000a0;<article-title>The sequence alignment/map format and SAMtools</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>2078</fpage>&#x02013;<lpage>2079</lpage>.<pub-id pub-id-type="pmid">19505943</pub-id>
</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Robinson</surname> &#x000a0;<given-names>D.G.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Storey</surname> &#x000a0;<given-names>J.D.</given-names></string-name>, <string-name><surname>Gresham</surname> &#x000a0;<given-names>D</given-names></string-name></person-group> &#x000a0;<article-title>Design and analysis of bar-seq experiments</article-title>. <source>G3 (Bethesda, Md.)</source>. <year>2014</year>; <volume>4</volume>:<fpage>11</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">24192834</pub-id>
</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Robinson</surname> &#x000a0;<given-names>M.D.</given-names></string-name>, <string-name><surname>McCarthy</surname> &#x000a0;<given-names>D.J.</given-names></string-name>, <string-name><surname>Smyth</surname> &#x000a0;<given-names>G.K.</given-names></string-name></person-group> &#x000a0;<article-title>edgeR: a bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source>. <year>2010</year>; <volume>26</volume>:<fpage>139</fpage>&#x02013;<lpage>140</lpage>.<pub-id pub-id-type="pmid">19910308</pub-id>
</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>de&#x000a0;Hoon</surname> &#x000a0;<given-names>M.J.</given-names></string-name>, <string-name><surname>Imoto</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Nolan</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Miyano</surname> &#x000a0;<given-names>S.</given-names></string-name></person-group> &#x000a0;<article-title>Open source clustering software</article-title>. <source>Bioinformatics</source>. <year>2004</year>; <volume>20</volume>:<fpage>1453</fpage>&#x02013;<lpage>1454</lpage>.<pub-id pub-id-type="pmid">14871861</pub-id>
</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Malik</surname> &#x000a0;<given-names>I.</given-names></string-name>, <string-name><surname>Qiu</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Snavely</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Kaplan</surname> &#x000a0;<given-names>C.D.</given-names></string-name></person-group> &#x000a0;<article-title>Wide-ranging and unexpected consequences of altered pol II catalytic activity in vivo</article-title>. <source>Nucleic Acids Res.</source> &#x000a0;<year>2017</year>; <volume>45</volume>:<fpage>4431</fpage>&#x02013;<lpage>4451</lpage>.<pub-id pub-id-type="pmid">28119420</pub-id>
</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kaplan</surname> &#x000a0;<given-names>C.D.</given-names></string-name>, <string-name><surname>Jin</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>I.L.</given-names></string-name>, <string-name><surname>Belyanin</surname> &#x000a0;<given-names>A.</given-names></string-name></person-group> &#x000a0;<article-title>Dissection of Pol II trigger loop function and pol II activity-dependent control of start site selection in vivo</article-title>. <source>PLoS Genet.</source> &#x000a0;<year>2012</year>; <volume>8</volume>:<fpage>e1002627</fpage>.<pub-id pub-id-type="pmid">22511879</pub-id>
</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Qiu</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Erinne</surname> &#x000a0;<given-names>O.C.</given-names></string-name>, <string-name><surname>Dave</surname> &#x000a0;<given-names>J.M.</given-names></string-name>, <string-name><surname>Cui</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Jin</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Muthukrishnan</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Tang</surname> &#x000a0;<given-names>L.K.</given-names></string-name>, <string-name><surname>Babu</surname> &#x000a0;<given-names>S.G.</given-names></string-name>, <string-name><surname>Lam</surname> &#x000a0;<given-names>K.C.</given-names></string-name>, <string-name><surname>Vandeventer</surname> &#x000a0;<given-names>P.J.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>High-resolution phenotypic landscape of the RNA polymerase II trigger loop</article-title>. <source>PLoS Genet.</source> &#x000a0;<year>2016</year>; <volume>12</volume>:<fpage>e1006321</fpage>.<pub-id pub-id-type="pmid">27898685</pub-id>
</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kaplan</surname> &#x000a0;<given-names>C.D.</given-names></string-name>, <string-name><surname>Larsson</surname> &#x000a0;<given-names>K.M.</given-names></string-name>, <string-name><surname>Kornberg</surname> &#x000a0;<given-names>R.D.</given-names></string-name></person-group> &#x000a0;<article-title>The RNA polymerase II trigger loop functions in substrate selection and is directly targeted by alpha-amanitin</article-title>. <source>Mol. Cell</source>. <year>2008</year>; <volume>30</volume>:<fpage>547</fpage>&#x02013;<lpage>556</lpage>.<pub-id pub-id-type="pmid">18538653</pub-id>
</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bolger</surname> &#x000a0;<given-names>A.M.</given-names></string-name>, <string-name><surname>Lohse</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Usadel</surname> &#x000a0;<given-names>B.</given-names></string-name></person-group> &#x000a0;<article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>. <source>Bioinformatics</source>. <year>2014</year>; <volume>30</volume>:<fpage>2114</fpage>&#x02013;<lpage>2120</lpage>.<pub-id pub-id-type="pmid">24695404</pub-id>
</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jeronimo</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Poitras</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Robert</surname> &#x000a0;<given-names>F.</given-names></string-name></person-group> &#x000a0;<article-title>Histone recycling by FACT and Spt6 during transcription prevents the scrambling of histone modifications</article-title>. <source>Cell Rep.</source> &#x000a0;<year>2019</year>; <volume>28</volume>:<fpage>1206</fpage>&#x02013;<lpage>1218</lpage>.<pub-id pub-id-type="pmid">31365865</pub-id>
</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zerbino</surname> &#x000a0;<given-names>D.R.</given-names></string-name>, <string-name><surname>Johnson</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Juettemann</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Wilder</surname> &#x000a0;<given-names>S.P.</given-names></string-name>, <string-name><surname>Flicek</surname> &#x000a0;<given-names>P.</given-names></string-name></person-group> &#x000a0;<article-title>WiggleTools: parallel processing of large collections of genome-wide datasets for visualization and statistical analysis</article-title>. <source>Bioinformatics</source>. <year>2014</year>; <volume>30</volume>:<fpage>1008</fpage>&#x02013;<lpage>1009</lpage>.<pub-id pub-id-type="pmid">24363377</pub-id>
</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ram&#x000ed;rez</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Ryan</surname> &#x000a0;<given-names>D.P.</given-names></string-name>, <string-name><surname>Gr&#x000fc;ning</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Bhardwaj</surname> &#x000a0;<given-names>V.</given-names></string-name>, <string-name><surname>Kilpert</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Richter</surname> &#x000a0;<given-names>A.S.</given-names></string-name>, <string-name><surname>Heyne</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>D&#x000fc;ndar</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Manke</surname> &#x000a0;<given-names>T.</given-names></string-name></person-group> &#x000a0;<article-title>deepTools2: a next generation web server for deep-sequencing data analysis</article-title>. <source>Nucleic Acids Res.</source> &#x000a0;<year>2016</year>; <volume>44</volume>:<fpage>W160</fpage>.<pub-id pub-id-type="pmid">27079975</pub-id>
</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kent</surname> &#x000a0;<given-names>W.J.</given-names></string-name>, <string-name><surname>Zweig</surname> &#x000a0;<given-names>A.S.</given-names></string-name>, <string-name><surname>Barber</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Hinrichs</surname> &#x000a0;<given-names>A.S.</given-names></string-name>, <string-name><surname>Karolchik</surname> &#x000a0;<given-names>D</given-names></string-name></person-group> &#x000a0;<article-title>BigWig and BigBed: enabling browsing of large distributed datasets</article-title>. <source>Bioinformatics</source>. <year>2010</year>; <volume>26</volume>:<fpage>2204</fpage>&#x02013;<lpage>2207</lpage>.<pub-id pub-id-type="pmid">20639541</pub-id>
</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Birkeland</surname> &#x000a0;<given-names>S.R.</given-names></string-name>, <string-name><surname>Jin</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Ozdemir</surname> &#x000a0;<given-names>A.C.</given-names></string-name>, <string-name><surname>Lyons</surname> &#x000a0;<given-names>R.H.</given-names> &#x000a0;<suffix>Jr.</suffix></string-name>, <string-name><surname>Weisman</surname> &#x000a0;<given-names>L.S.</given-names></string-name>, <string-name><surname>Wilson</surname> &#x000a0;<given-names>T.E</given-names></string-name></person-group> &#x000a0;<article-title>Discovery of mutations in <italic toggle="yes">Saccharomyces cerevisiae</italic> by pooled linkage analysis and whole-genome sequencing</article-title>. <source>Genetics</source>. <year>2010</year>; <volume>186</volume>:<fpage>1127</fpage>&#x02013;<lpage>1137</lpage>.<pub-id pub-id-type="pmid">20923977</pub-id>
</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Karim</surname> &#x000a0;<given-names>A.S.</given-names></string-name>, <string-name><surname>Curran</surname> &#x000a0;<given-names>K.A.</given-names></string-name>, <string-name><surname>Alper</surname> &#x000a0;<given-names>H.S.</given-names></string-name></person-group> &#x000a0;<article-title>Characterization of plasmid burden and copy number in <italic toggle="yes">Saccharomyces cerevisiae</italic> for optimization of metabolic engineering applications</article-title>. <source>FEMS Yeast Res.</source> &#x000a0;<year>2013</year>; <volume>13</volume>:<fpage>107</fpage>&#x02013;<lpage>116</lpage>.<pub-id pub-id-type="pmid">23107142</pub-id>
</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kuge</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Jones</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Nomoto</surname> &#x000a0;<given-names>A.</given-names></string-name></person-group> &#x000a0;<article-title>Regulation of yAP-1 nuclear localization in response to oxidative stress</article-title>. <source>EMBO J.</source> &#x000a0;<year>1997</year>; <volume>16</volume>:<fpage>1710</fpage>&#x02013;<lpage>1720</lpage>.<pub-id pub-id-type="pmid">9130715</pub-id>
</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wemmie</surname> &#x000a0;<given-names>J.A.</given-names></string-name>, <string-name><surname>Steggerda</surname> &#x000a0;<given-names>S.M.</given-names></string-name>, <string-name><surname>Moye-Rowley</surname> &#x000a0;<given-names>W.S.</given-names></string-name></person-group> &#x000a0;<article-title>The <italic toggle="yes">Saccharomyces cerevisiae</italic> AP-1 protein discriminates between oxidative stress elicited by the oxidants H2O2 and diamide</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>1997</year>; <volume>272</volume>:<fpage>7908</fpage>&#x02013;<lpage>7914</lpage>.<pub-id pub-id-type="pmid">9065458</pub-id>
</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Coleman</surname> &#x000a0;<given-names>S.T.</given-names></string-name>, <string-name><surname>Epping</surname> &#x000a0;<given-names>E.A.</given-names></string-name>, <string-name><surname>Steggerda</surname> &#x000a0;<given-names>S.M.</given-names></string-name>, <string-name><surname>Moye-Rowley</surname> &#x000a0;<given-names>W.S.</given-names></string-name></person-group> &#x000a0;<article-title>Yap1p activates gene transcription in an oxidant-specific fashion</article-title>. <source>Mol. Cell Biol.</source> &#x000a0;<year>1999</year>; <volume>19</volume>:<fpage>8302</fpage>&#x02013;<lpage>8313</lpage>.<pub-id pub-id-type="pmid">10567555</pub-id>
</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kuge</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Arita</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Murayama</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Maeta</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Izawa</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Inoue</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Nomoto</surname> &#x000a0;<given-names>A.</given-names></string-name></person-group> &#x000a0;<article-title>Regulation of the yeast Yap1p nuclear export signal is mediated by redox signal-induced reversible disulfide bond formation</article-title>. <source>Mol. Cell Biol.</source> &#x000a0;<year>2001</year>; <volume>21</volume>:<fpage>6139</fpage>&#x02013;<lpage>6150</lpage>.<pub-id pub-id-type="pmid">11509657</pub-id>
</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gulshan</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Rovinsky</surname> &#x000a0;<given-names>S.A.</given-names></string-name>, <string-name><surname>Coleman</surname> &#x000a0;<given-names>S.T.</given-names></string-name>, <string-name><surname>Moye-Rowley</surname> &#x000a0;<given-names>W.S.</given-names></string-name></person-group> &#x000a0;<article-title>Oxidant-specific folding of Yap1p regulates both transcriptional activation and nuclear localization</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>2005</year>; <volume>280</volume>:<fpage>40524</fpage>&#x02013;<lpage>40533</lpage>.<pub-id pub-id-type="pmid">16219769</pub-id>
</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Alarco</surname> &#x000a0;<given-names>A.M.</given-names></string-name>, <string-name><surname>Balan</surname> &#x000a0;<given-names>I.</given-names></string-name>, <string-name><surname>Talibi</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Mainville</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Raymond</surname> &#x000a0;<given-names>M.</given-names></string-name></person-group> &#x000a0;<article-title>AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>1997</year>; <volume>272</volume>:<fpage>19304</fpage>&#x02013;<lpage>19313</lpage>.<pub-id pub-id-type="pmid">9235926</pub-id>
</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Coleman</surname> &#x000a0;<given-names>S.T.</given-names></string-name>, <string-name><surname>Tseng</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Moye-Rowley</surname> &#x000a0;<given-names>W.S.</given-names></string-name></person-group> &#x000a0;<article-title>Saccharomyces cerevisiae basic region-leucine zipper protein regulatory networks converge at the ATR1 structural gene</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>1997</year>; <volume>272</volume>:<fpage>23224</fpage>&#x02013;<lpage>23230</lpage>.<pub-id pub-id-type="pmid">9287330</pub-id>
</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gulshan</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Moye-Rowley</surname> &#x000a0;<given-names>W.S.</given-names></string-name></person-group> &#x000a0;<article-title>Multidrug resistance in fungi</article-title>. <source>Euk. Cell</source>. <year>2007</year>; <volume>6</volume>:<fpage>1933</fpage>&#x02013;<lpage>1942</lpage>.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Meyer</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Buchanan</surname> &#x000a0;<given-names>B.B.</given-names></string-name>, <string-name><surname>Vignols</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Reichheld</surname> &#x000a0;<given-names>J.P.</given-names></string-name></person-group> &#x000a0;<article-title>Thioredoxins and glutaredoxins: unifying elements in redox biology</article-title>. <source>Annu. Rev. Genet.</source> &#x000a0;<year>2009</year>; <volume>43</volume>:<fpage>335</fpage>&#x02013;<lpage>367</lpage>.<pub-id pub-id-type="pmid">19691428</pub-id>
</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Winzeler</surname> &#x000a0;<given-names>E.A.</given-names></string-name>, <string-name><surname>Shoemaker</surname> &#x000a0;<given-names>D.D.</given-names></string-name>, <string-name><surname>Astromoff</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Liang</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Anderson</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Andre</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Bangham</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Benito</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Boeke</surname> &#x000a0;<given-names>J.D.</given-names></string-name>, <string-name><surname>Bussey</surname> &#x000a0;<given-names>H.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis</article-title>. <source>Science</source>. <year>1999</year>; <volume>285</volume>:<fpage>901</fpage>&#x02013;<lpage>906</lpage>.<pub-id pub-id-type="pmid">10436161</pub-id>
</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Machado</surname> &#x000a0;<given-names>A.K.</given-names></string-name>, <string-name><surname>Morgan</surname> &#x000a0;<given-names>B.A.</given-names></string-name>, <string-name><surname>Merrill</surname> &#x000a0;<given-names>G.F.</given-names></string-name></person-group> &#x000a0;<article-title>Thioredoxin reductase-dependent inhibition of MCB cell cycle box activity in Saccharomyces cerevisiae</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>1997</year>; <volume>272</volume>:<fpage>17045</fpage>&#x02013;<lpage>17054</lpage>.<pub-id pub-id-type="pmid">9202020</pub-id>
</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Carmel-Harel</surname> &#x000a0;<given-names>O.</given-names></string-name>, <string-name><surname>Stearman</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Gasch</surname> &#x000a0;<given-names>A.P.</given-names></string-name>, <string-name><surname>Botstein</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Brown</surname> &#x000a0;<given-names>P.O.</given-names></string-name>, <string-name><surname>Storz</surname> &#x000a0;<given-names>G.</given-names></string-name></person-group> &#x000a0;<article-title>Role of thioredoxin reductase in the Yap1p-dependent response to oxidative stress in Saccharomyces cerevisiae</article-title>. <source>Mol. Microbiol.</source> &#x000a0;<year>2001</year>; <volume>39</volume>:<fpage>595</fpage>&#x02013;<lpage>605</lpage>.<pub-id pub-id-type="pmid">11169101</pub-id>
</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Trotter</surname> &#x000a0;<given-names>E.W.</given-names></string-name>, <string-name><surname>Grant</surname> &#x000a0;<given-names>C.M.</given-names></string-name></person-group> &#x000a0;<article-title>Thioredoxins are required for protection against a reductive stress in the yeast saccharomyces cerevisiae</article-title>. <source>Mol. Microbiol.</source> &#x000a0;<year>2002</year>; <volume>46</volume>:<fpage>869</fpage>&#x02013;<lpage>878</lpage>.<pub-id pub-id-type="pmid">12410842</pub-id>
</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hacioglu</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Esmer</surname> &#x000a0;<given-names>I.</given-names></string-name>, <string-name><surname>Fomenko</surname> &#x000a0;<given-names>D.E.</given-names></string-name>, <string-name><surname>Gladyshev</surname> &#x000a0;<given-names>V.N.</given-names></string-name>, <string-name><surname>Koc</surname> &#x000a0;<given-names>A.</given-names></string-name></person-group> &#x000a0;<article-title>The roles of thiol oxidoreductases in yeast replicative aging</article-title>. <source>Mech. Ageing Dev.</source> &#x000a0;<year>2010</year>; <volume>131</volume>:<fpage>692</fpage>&#x02013;<lpage>699</lpage>.<pub-id pub-id-type="pmid">20934449</pub-id>
</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ragu</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Dardalhon</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Sharma</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Iraqui</surname> &#x000a0;<given-names>I.</given-names></string-name>, <string-name><surname>Buhagiar-Labarchede</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Grondin</surname> &#x000a0;<given-names>V.</given-names></string-name>, <string-name><surname>Kienda</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Vernis</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Chanet</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Kolodner</surname> &#x000a0;<given-names>R.D.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>Loss of the thioredoxin reductase Trr1 suppresses the genomic instability of peroxiredoxin tsa1 mutants</article-title>. <source>PLoS One</source>. <year>2014</year>; <volume>9</volume>:<fpage>e108123</fpage>.<pub-id pub-id-type="pmid">25247923</pub-id>
</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Grant</surname> &#x000a0;<given-names>C.M.</given-names></string-name>, <string-name><surname>Perrone</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Dawes</surname> &#x000a0;<given-names>I.W.</given-names></string-name></person-group> &#x000a0;<article-title>Glutathione and Catalase provide overlapping defenses for protection against hydrogen peroxide in the YeastSaccharomyces cerevisiae</article-title>. <source>Biochem. Biophys. Res. Commun.</source> &#x000a0;<year>1998</year>; <volume>253</volume>:<fpage>893</fpage>&#x02013;<lpage>898</lpage>.<pub-id pub-id-type="pmid">9918826</pub-id>
</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Castro</surname> &#x000a0;<given-names>F.A.</given-names></string-name>, <string-name><surname>Mariani</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Panek</surname> &#x000a0;<given-names>A.D.</given-names></string-name>, <string-name><surname>Eleutherio</surname> &#x000a0;<given-names>E.C.</given-names></string-name>, <string-name><surname>Pereira</surname> &#x000a0;<given-names>M.D.</given-names></string-name></person-group> &#x000a0;<article-title>Cytotoxicity mechanism of two naphthoquinones (menadione and plumbagin) in Saccharomyces cerevisiae</article-title>. <source>PLoS One</source>. <year>2008</year>; <volume>3</volume>:<fpage>e3999</fpage>.<pub-id pub-id-type="pmid">19098979</pub-id>
</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Toledano</surname> &#x000a0;<given-names>M.B.</given-names></string-name>, <string-name><surname>Delaunay-Moisan</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Outten</surname> &#x000a0;<given-names>C.E.</given-names></string-name>, <string-name><surname>Igbaria</surname> &#x000a0;<given-names>A.</given-names></string-name></person-group> &#x000a0;<article-title>Functions and cellular compartmentation of the thioredoxin and glutathione pathways in yeast</article-title>. <source>Antioxid. Redox. Signal.</source> &#x000a0;<year>2013</year>; <volume>18</volume>:<fpage>1699</fpage>&#x02013;<lpage>1711</lpage>.<pub-id pub-id-type="pmid">23198979</pub-id>
</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jung</surname> &#x000a0;<given-names>U.</given-names></string-name>, <string-name><surname>Zheng</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Yoon</surname> &#x000a0;<given-names>S.O.</given-names></string-name>, <string-name><surname>Chung</surname> &#x000a0;<given-names>A.S.</given-names></string-name></person-group> &#x000a0;<article-title>Se-methylselenocysteine induces apoptosis mediated by reactive oxygen species in HL-60 cells</article-title>. <source>Free Radic Biol. Med.</source> &#x000a0;<year>2001</year>; <volume>31</volume>:<fpage>479</fpage>&#x02013;<lpage>489</lpage>.<pub-id pub-id-type="pmid">11498281</pub-id>
</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ravi</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Das</surname> &#x000a0;<given-names>K.C.</given-names></string-name></person-group> &#x000a0;<article-title>Redox-cycling of anthracyclines by thioredoxin system: increased superoxide generation and DNA damage</article-title>. <source>Cancer Chemother. Pharmacol.</source> &#x000a0;<year>2004</year>; <volume>54</volume>:<fpage>449</fpage>&#x02013;<lpage>458</lpage>.<pub-id pub-id-type="pmid">15290096</pub-id>
</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jimenez</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Tipper</surname> &#x000a0;<given-names>D.J.</given-names></string-name>, <string-name><surname>Davies</surname> &#x000a0;<given-names>J.</given-names></string-name></person-group> &#x000a0;<article-title>Mode of action of thiolutin, an inhibitor of macromolecular synthesis in Saccharomyces cerevisiae</article-title>. <source>Antimicrob. Agents Chemother.</source> &#x000a0;<year>1973</year>; <volume>3</volume>:<fpage>729</fpage>&#x02013;<lpage>738</lpage>.<pub-id pub-id-type="pmid">4597739</pub-id>
</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Dudley</surname> &#x000a0;<given-names>A.M.</given-names></string-name>, <string-name><surname>Janse</surname> &#x000a0;<given-names>D.M.</given-names></string-name>, <string-name><surname>Tanay</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Shamir</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Church</surname> &#x000a0;<given-names>G.M.</given-names></string-name></person-group> &#x000a0;<article-title>A global view of pleiotropy and phenotypically derived gene function in yeast</article-title>. <source>Mol. Syst. Biol.</source> &#x000a0;<year>2005</year>; <volume>1</volume>:<fpage>2005 0001</fpage>.</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pagani</surname> &#x000a0;<given-names>M.A.</given-names></string-name>, <string-name><surname>Casamayor</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Serrano</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Atrian</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Arino</surname> &#x000a0;<given-names>J.</given-names></string-name></person-group> &#x000a0;<article-title>Disruption of iron homeostasis in Saccharomyces cerevisiae by high zinc levels: a genome-wide study</article-title>. <source>Mol. Microbiol.</source> &#x000a0;<year>2007</year>; <volume>65</volume>:<fpage>521</fpage>&#x02013;<lpage>537</lpage>.<pub-id pub-id-type="pmid">17630978</pub-id>
</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ruotolo</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Marchini</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Ottonello</surname> &#x000a0;<given-names>S.</given-names></string-name></person-group> &#x000a0;<article-title>Membrane transporters and protein traffic networks differentially affecting metal tolerance: a genomic phenotyping study in yeast</article-title>. <source>Genome Biol.</source> &#x000a0;<year>2008</year>; <volume>9</volume>:<fpage>R67</fpage>.<pub-id pub-id-type="pmid">18394190</pub-id>
</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bleackley</surname> &#x000a0;<given-names>M.R.</given-names></string-name>, <string-name><surname>Young</surname> &#x000a0;<given-names>B.P.</given-names></string-name>, <string-name><surname>Loewen</surname> &#x000a0;<given-names>C.J.</given-names></string-name>, <string-name><surname>MacGillivray</surname> &#x000a0;<given-names>R.T.</given-names></string-name></person-group> &#x000a0;<article-title>High density array screening to identify the genetic requirements for transition metal tolerance in Saccharomyces cerevisiae</article-title>. <source>Metallomics</source>. <year>2011</year>; <volume>3</volume>:<fpage>195</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="pmid">21212869</pub-id>
</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jiang</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Cao</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Lin</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Xia</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Xu</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> &#x000a0;<article-title>Cadmium-induced activation of high osmolarity glycerol pathway through its Sln1 branch is dependent on the MAP kinase kinase kinase Ssk2, but not its paralog Ssk22, in budding yeast</article-title>. <source>FEMS Yeast Res.</source> &#x000a0;<year>2014</year>; <volume>14</volume>:<fpage>1263</fpage>&#x02013;<lpage>1272</lpage>.<pub-id pub-id-type="pmid">25331360</pub-id>
</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Acosta-Alvear</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>M.Y.</given-names></string-name>, <string-name><surname>Wild</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Buchholz</surname> &#x000a0;<given-names>T.J.</given-names></string-name>, <string-name><surname>Lerner</surname> &#x000a0;<given-names>A.G.</given-names></string-name>, <string-name><surname>Simakova</surname> &#x000a0;<given-names>O.</given-names></string-name>, <string-name><surname>Hahn</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Korde</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Landgren</surname> &#x000a0;<given-names>O.</given-names></string-name>, <string-name><surname>Maric</surname> &#x000a0;<given-names>I.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits</article-title>. <source>eLife</source>. <year>2015</year>; <volume>4</volume>:<fpage>e08153</fpage>.<pub-id pub-id-type="pmid">26327694</pub-id>
</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tsvetkov</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Mendillo</surname> &#x000a0;<given-names>M.L.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Carette</surname> &#x000a0;<given-names>J.E.</given-names></string-name>, <string-name><surname>Merrill</surname> &#x000a0;<given-names>P.H.</given-names></string-name>, <string-name><surname>Cikes</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Varadarajan</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>van&#x000a0;Diemen</surname> &#x000a0;<given-names>F.R.</given-names></string-name>, <string-name><surname>Penninger</surname> &#x000a0;<given-names>J.M.</given-names></string-name>, <string-name><surname>Goldberg</surname> &#x000a0;<given-names>A.L.</given-names></string-name></person-group> &#x000a0;<article-title>Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome</article-title>. <source>eLife</source>. <year>2015</year>; <volume>4</volume>:<fpage>e08467</fpage>.<pub-id pub-id-type="pmid">26327695</pub-id>
</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tsvetkov</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Sokol</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Jin</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Brune</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Thiru</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Ghandi</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Garraway</surname> &#x000a0;<given-names>L.A.</given-names></string-name>, <string-name><surname>Gupta</surname> &#x000a0;<given-names>P.B.</given-names></string-name>, <string-name><surname>Santagata</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Whitesell</surname> &#x000a0;<given-names>L.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>Suppression of 19S proteasome subunits marks emergence of an altered cell state in diverse cancers</article-title>. <source>Proc. Nat. Acad. Sci. U.S.A.</source> &#x000a0;<year>2017</year>; <volume>114</volume>:<fpage>382</fpage>&#x02013;<lpage>387</lpage>.</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bandara</surname> &#x000a0;<given-names>P.D.</given-names></string-name>, <string-name><surname>Flattery-O&#x02019;Brien</surname> &#x000a0;<given-names>J.A.</given-names></string-name>, <string-name><surname>Grant</surname> &#x000a0;<given-names>C.M.</given-names></string-name>, <string-name><surname>Dawes</surname> &#x000a0;<given-names>I.W.</given-names></string-name></person-group> &#x000a0;<article-title>Involvement of the Saccharomyces cerevisiae UTH1 gene in the oxidative-stress response</article-title>. <source>Curr. Genet.</source> &#x000a0;<year>1998</year>; <volume>34</volume>:<fpage>259</fpage>&#x02013;<lpage>268</lpage>.<pub-id pub-id-type="pmid">9799359</pub-id>
</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wu</surname> &#x000a0;<given-names>C.-Y.</given-names></string-name>, <string-name><surname>Bird</surname> &#x000a0;<given-names>A.J.</given-names></string-name>, <string-name><surname>Winge</surname> &#x000a0;<given-names>D.R.</given-names></string-name>, <string-name><surname>Eide</surname> &#x000a0;<given-names>D.J.</given-names></string-name></person-group> &#x000a0;<article-title>Regulation of the yeast TSA1 peroxiredoxin by ZAP1 is an adaptive response to the oxidative stress of zinc deficiency</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>2007</year>; <volume>282</volume>:<fpage>2184</fpage>&#x02013;<lpage>2195</lpage>.<pub-id pub-id-type="pmid">17121842</pub-id>
</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wu</surname> &#x000a0;<given-names>C.-Y.</given-names></string-name>, <string-name><surname>Roje</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Sandoval</surname> &#x000a0;<given-names>F.J.</given-names></string-name>, <string-name><surname>Bird</surname> &#x000a0;<given-names>A.J.</given-names></string-name>, <string-name><surname>Winge</surname> &#x000a0;<given-names>D.R.</given-names></string-name>, <string-name><surname>Eide</surname> &#x000a0;<given-names>D.J.</given-names></string-name></person-group> &#x000a0;<article-title>Repression of sulfate assimilation is an adaptive response of yeast to the oxidative stress of zinc deficiency</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>2009</year>; <volume>284</volume>:<fpage>27544</fpage>&#x02013;<lpage>27556</lpage>.<pub-id pub-id-type="pmid">19656949</pub-id>
</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wu</surname> &#x000a0;<given-names>C.-Y.</given-names></string-name>, <string-name><surname>Steffen</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Eide</surname> &#x000a0;<given-names>D.J.</given-names></string-name></person-group> &#x000a0;<article-title>Cytosolic superoxide dismutase (SOD1) is critical for tolerating the oxidative stress of zinc deficiency in yeast</article-title>. <source>PLoS One</source>. <year>2009</year>; <volume>4</volume>:<fpage>e7061</fpage>.<pub-id pub-id-type="pmid">19756144</pub-id>
</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Rudolph</surname> &#x000a0;<given-names>H.K.</given-names></string-name>, <string-name><surname>Antebi</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Fink</surname> &#x000a0;<given-names>G.R.</given-names></string-name>, <string-name><surname>Buckley</surname> &#x000a0;<given-names>C.M.</given-names></string-name>, <string-name><surname>Dorman</surname> &#x000a0;<given-names>T.E.</given-names></string-name>, <string-name><surname>LeVitre</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Davidow</surname> &#x000a0;<given-names>L.S.</given-names></string-name>, <string-name><surname>Mao</surname> &#x000a0;<given-names>J.I.</given-names></string-name>, <string-name><surname>Moir</surname> &#x000a0;<given-names>D.T.</given-names></string-name></person-group> &#x000a0;<article-title>The yeast secretory pathway is perturbed by mutations in PMR1, a member of a Ca2+ ATPase family</article-title>. <source>Cell</source>. <year>1989</year>; <volume>58</volume>:<fpage>133</fpage>&#x02013;<lpage>145</lpage>.<pub-id pub-id-type="pmid">2526682</pub-id>
</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mandal</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Woolf</surname> &#x000a0;<given-names>T.B.</given-names></string-name>, <string-name><surname>Rao</surname> &#x000a0;<given-names>R.</given-names></string-name></person-group> &#x000a0;<article-title>Manganese selectivity of pmr1, the yeast secretory pathway ion pump, is defined by residue gln783 in transmembrane segment 6. Residue Asp778 is essential for cation transport</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>2000</year>; <volume>275</volume>:<fpage>23933</fpage>&#x02013;<lpage>23938</lpage>.<pub-id pub-id-type="pmid">10801856</pub-id>
</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zencir</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Dilg</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Shore</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Albert</surname> &#x000a0;<given-names>B.</given-names></string-name></person-group> &#x000a0;<article-title>Pitfalls in using phenanthroline to study the causal relationship between promoter nucleosome acetylation and transcription</article-title>. <source>Nat. Commun.</source> &#x000a0;<year>2022</year>; <volume>13</volume>:<fpage>3726</fpage>.<pub-id pub-id-type="pmid">35768402</pub-id>
</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Grigull</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Mnaimneh</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Pootoolal</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Robinson</surname> &#x000a0;<given-names>M.D.</given-names></string-name>, <string-name><surname>Hughes</surname> &#x000a0;<given-names>T.R.</given-names></string-name></person-group> &#x000a0;<article-title>Genome-wide analysis of mRNA stability using transcription inhibitors and microarrays reveals posttranscriptional control of ribosome biogenesis factors</article-title>. <source>Mol. Cell. Biol.</source> &#x000a0;<year>2004</year>; <volume>24</volume>:<fpage>5534</fpage>&#x02013;<lpage>5547</lpage>.<pub-id pub-id-type="pmid">15169913</pub-id>
</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sun</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Schwalb</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Pirkl</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Maier</surname> &#x000a0;<given-names>K.C.</given-names></string-name>, <string-name><surname>Schenk</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Failmezger</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Tresch</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Cramer</surname> &#x000a0;<given-names>P.</given-names></string-name></person-group> &#x000a0;<article-title>Global analysis of eukaryotic mRNA degradation reveals Xrn1-dependent buffering of transcript levels</article-title>. <source>Mol. Cell</source>. <year>2013</year>; <volume>52</volume>:<fpage>52</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">24119399</pub-id>
</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>D&#x02019;Aurora</surname> &#x000a0;<given-names>V.</given-names></string-name>, <string-name><surname>Stern</surname> &#x000a0;<given-names>A.M.</given-names></string-name>, <string-name><surname>Sigman</surname> &#x000a0;<given-names>D.S.</given-names></string-name></person-group> &#x000a0;<article-title>1,10-Phenanthroline-cuprous ion complex, a potent inhibitor of DNA and RNA polymerases</article-title>. <source>Biochem. Biophys. Res. Commun.</source> &#x000a0;<year>1978</year>; <volume>80</volume>:<fpage>1025</fpage>&#x02013;<lpage>1032</lpage>.<pub-id pub-id-type="pmid">346019</pub-id>
</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Reimann</surname> &#x000a0;<given-names>C.W.</given-names></string-name>, <string-name><surname>Block</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Perloff</surname> &#x000a0;<given-names>A.</given-names></string-name></person-group> &#x000a0;<article-title>The crystal and molecular structure of dichloro (1, 10-phenanthroline) zinc</article-title>. <source>Inorg. Chem.</source> &#x000a0;<year>1966</year>; <volume>5</volume>:<fpage>1185</fpage>&#x02013;<lpage>1189</lpage>.</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Niyogi</surname> &#x000a0;<given-names>S.K.</given-names></string-name>, <string-name><surname>Feldman</surname> &#x000a0;<given-names>R.P.</given-names></string-name>, <string-name><surname>Hoffman</surname> &#x000a0;<given-names>D.J.</given-names></string-name></person-group> &#x000a0;<article-title>Selective effects of metal ions on RNA synthesis rates</article-title>. <source>Toxicology</source>. <year>1981</year>; <volume>22</volume>:<fpage>9</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">6175051</pub-id>
</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lin</surname> &#x000a0;<given-names>S.-J.</given-names></string-name>, <string-name><surname>Culotta</surname> &#x000a0;<given-names>V.C.</given-names></string-name></person-group> &#x000a0;<article-title>Suppression of oxidative damage by <italic toggle="yes">Saccharomyces cerevisiae</italic> ATX2, which encodes a manganese-trafficking protein that localizes to Golgi-like vesicles</article-title>. <source>Mol. Cell. Biol.</source> &#x000a0;<year>1996</year>; <volume>16</volume>:<fpage>6303</fpage>&#x02013;<lpage>6312</lpage>.<pub-id pub-id-type="pmid">8887660</pub-id>
</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Portnoy</surname> &#x000a0;<given-names>M.E.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>X.F.</given-names></string-name>, <string-name><surname>Culotta</surname> &#x000a0;<given-names>V.C.</given-names></string-name></person-group> &#x000a0;<article-title>Saccharomyces cerevisiae expresses three functionally distinct homologues of the nramp family of metal transporters</article-title>. <source>Mol. Cell. Biol.</source> &#x000a0;<year>2000</year>; <volume>20</volume>:<fpage>7893</fpage>&#x02013;<lpage>7902</lpage>.<pub-id pub-id-type="pmid">11027260</pub-id>
</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jensen</surname> &#x000a0;<given-names>L.T.</given-names></string-name>, <string-name><surname>Ajua-Alemanji</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Culotta</surname> &#x000a0;<given-names>V.C.</given-names></string-name></person-group> &#x000a0;<article-title>The <italic toggle="yes">Saccharomyces cerevisiae</italic> high affinity phosphate transporter encoded by PHO84 also functions in manganese homeostasis</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>2003</year>; <volume>278</volume>:<fpage>42036</fpage>&#x02013;<lpage>42040</lpage>.<pub-id pub-id-type="pmid">12923174</pub-id>
</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mei</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Jensen</surname> &#x000a0;<given-names>L.T.</given-names></string-name>, <string-name><surname>Gardner</surname> &#x000a0;<given-names>A.J.</given-names></string-name>, <string-name><surname>Culotta</surname> &#x000a0;<given-names>V.C.</given-names></string-name></person-group> &#x000a0;<article-title>Manganese toxicity and <italic toggle="yes">Saccharomyces cerevisiae</italic> Mam3p, a member of the ACDP (ancient conserved domain protein) family</article-title>. <source>Biochem. J.</source> &#x000a0;<year>2005</year>; <volume>386</volume>:<fpage>479</fpage>&#x02013;<lpage>487</lpage>.<pub-id pub-id-type="pmid">15498024</pub-id>
</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Reddi</surname> &#x000a0;<given-names>A.R.</given-names></string-name>, <string-name><surname>Jensen</surname> &#x000a0;<given-names>L.T.</given-names></string-name>, <string-name><surname>Naranuntarat</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Rosenfeld</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Leung</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Shah</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Culotta</surname> &#x000a0;<given-names>V.C.</given-names></string-name></person-group> &#x000a0;<article-title>The overlapping roles of manganese and Cu/Zn SOD in oxidative stress protection</article-title>. <source>Free Radic Biol. Med.</source> &#x000a0;<year>2009</year>; <volume>46</volume>:<fpage>154</fpage>&#x02013;<lpage>162</lpage>.<pub-id pub-id-type="pmid">18973803</pub-id>
</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Walmacq</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Kireeva</surname> &#x000a0;<given-names>M.L.</given-names></string-name>, <string-name><surname>Irvin</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Nedialkov</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Lubkowska</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Malagon</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Strathern</surname> &#x000a0;<given-names>J.N.</given-names></string-name>, <string-name><surname>Kashlev</surname> &#x000a0;<given-names>M.</given-names></string-name></person-group> &#x000a0;<article-title>Rpb9 subunit controls transcription fidelity by delaying NTP sequestration in RNA polymerase II</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>2009</year>; <volume>284</volume>:<fpage>19601</fpage>&#x02013;<lpage>19612</lpage>.<pub-id pub-id-type="pmid">19439405</pub-id>
</mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Urban</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Soulard</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Huber</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Lippman</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Mukhopadhyay</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Deloche</surname> &#x000a0;<given-names>O.</given-names></string-name>, <string-name><surname>Wanke</surname> &#x000a0;<given-names>V.</given-names></string-name>, <string-name><surname>Anrather</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Ammerer</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Riezman</surname> &#x000a0;<given-names>H.</given-names></string-name></person-group> &#x000a0;<article-title>Sch9 is a major target of TORC1 in Saccharomyces cerevisiae</article-title>. <source>Mol. Cell</source>. <year>2007</year>; <volume>26</volume>:<fpage>663</fpage>&#x02013;<lpage>674</lpage>.<pub-id pub-id-type="pmid">17560372</pub-id>
</mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pecci</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Montefoschi</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Musci</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Cavallini</surname> &#x000a0;<given-names>D</given-names></string-name></person-group> &#x000a0;<article-title>Novel findings on the copper catalysed oxidation of cysteine</article-title>. <source>Amino Acids</source>. <year>1997</year>; <volume>13</volume>:<fpage>355</fpage>&#x02013;<lpage>367</lpage>.</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Prudent</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Girault</surname> &#x000a0;<given-names>H.H.</given-names></string-name></person-group> &#x000a0;<article-title>The role of copper in cysteine oxidation: study of intra- and inter-molecular reactions in mass spectrometry</article-title>. <source>Metallomics</source>. <year>2009</year>; <volume>1</volume>:<fpage>157</fpage>&#x02013;<lpage>165</lpage>.<pub-id pub-id-type="pmid">21305109</pub-id>
</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fetherolf</surname> &#x000a0;<given-names>M.M.</given-names></string-name>, <string-name><surname>Boyd</surname> &#x000a0;<given-names>S.D.</given-names></string-name>, <string-name><surname>Taylor</surname> &#x000a0;<given-names>A.B.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>H.J.</given-names></string-name>, <string-name><surname>Wohlschlegel</surname> &#x000a0;<given-names>J.A.</given-names></string-name>, <string-name><surname>Blackburn</surname> &#x000a0;<given-names>N.J.</given-names></string-name>, <string-name><surname>Hart</surname> &#x000a0;<given-names>P.J.</given-names></string-name>, <string-name><surname>Winge</surname> &#x000a0;<given-names>D.R.</given-names></string-name>, <string-name><surname>Winkler</surname> &#x000a0;<given-names>D.D.</given-names></string-name></person-group> &#x000a0;<article-title>Copper-zinc superoxide dismutase is activated through a sulfenic acid intermediate at a copper ion entry site</article-title>. <source>J. Biol. Chem.</source> &#x000a0;<year>2017</year>; <volume>292</volume>:<fpage>12025</fpage>&#x02013;<lpage>12040</lpage>.<pub-id pub-id-type="pmid">28533431</pub-id>
</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sergio</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Pirali</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>White</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Parenti</surname> &#x000a0;<given-names>F.</given-names></string-name></person-group> &#x000a0;<article-title>Lipiarmycin, a new antibiotic from Actinoplanes III. Mechanism of action</article-title>. <source>J. Antibiot. (Tokyo)</source>. <year>1975</year>; <volume>28</volume>:<fpage>543</fpage>&#x02013;<lpage>549</lpage>.<pub-id pub-id-type="pmid">807550</pub-id>
</mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Talpaert</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Campagnari</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Clerici</surname> &#x000a0;<given-names>L.</given-names></string-name></person-group> &#x000a0;<article-title>Lipiarmycin: an antibiotic inhibiting nucleic acid polymerases</article-title>. <source>Biochem. Biophys. Res. Commun.</source> &#x000a0;<year>1975</year>; <volume>63</volume>:<fpage>328</fpage>&#x02013;<lpage>334</lpage>.<pub-id pub-id-type="pmid">1092299</pub-id>
</mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Sonenshein</surname> &#x000a0;<given-names>A.L.</given-names></string-name>, <string-name><surname>Alexander</surname> &#x000a0;<given-names>H.B.</given-names></string-name></person-group> &#x000a0;<article-title>Initiation of transcription in vitro is inhibited by lipiarmycin</article-title>. <source>J. Mol. Biol.</source> &#x000a0;<year>1979</year>; <volume>127</volume>:<fpage>55</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">106131</pub-id>
</mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Srivastava</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Talaue</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Degen</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Ebright</surname> &#x000a0;<given-names>R.Y.</given-names></string-name>, <string-name><surname>Sineva</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Chakraborty</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Druzhinin</surname> &#x000a0;<given-names>S.Y.</given-names></string-name>, <string-name><surname>Chatterjee</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Mukhopadhyay</surname> &#x000a0;<given-names>J.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>New target for inhibition of bacterial RNA polymerase: &#x02018;switch region</article-title>. <source>Curr. Opin. Microbiol.</source> &#x000a0;<year>2011</year>; <volume>14</volume>:<fpage>532</fpage>&#x02013;<lpage>543</lpage>.<pub-id pub-id-type="pmid">21862392</pub-id>
</mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chakraborty</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Ebright</surname> &#x000a0;<given-names>Y.W.</given-names></string-name>, <string-name><surname>Korlann</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Kortkhonjia</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Chowdhury</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Wigneshweraraj</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Irschik</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Jansen</surname> &#x000a0;<given-names>R.</given-names></string-name> &#x000a0;<etal>et al</etal>.</person-group> &#x000a0;<article-title>Opening and closing of the bacterial RNA polymerase clamp</article-title>. <source>Science</source>. <year>2012</year>; <volume>337</volume>:<fpage>591</fpage>&#x02013;<lpage>595</lpage>.<pub-id pub-id-type="pmid">22859489</pub-id>
</mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Adams</surname> &#x000a0;<given-names>C.C.</given-names></string-name>, <string-name><surname>Gross</surname> &#x000a0;<given-names>D.S.</given-names></string-name></person-group> &#x000a0;<article-title>The yeast heat shock response is induced by conversion of cells to spheroplasts and by potent transcriptional inhibitors</article-title>. <source>J. Bacteriol.</source> &#x000a0;<year>1991</year>; <volume>173</volume>:<fpage>7429</fpage>&#x02013;<lpage>7435</lpage>.<pub-id pub-id-type="pmid">1938939</pub-id>
</mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Nayak</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Voss</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Windgassen</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Mooney</surname> &#x000a0;<given-names>R.A.</given-names></string-name>, <string-name><surname>Landick</surname> &#x000a0;<given-names>R.</given-names></string-name></person-group> &#x000a0;<article-title>Cys-pair reporters detect a constrained trigger loop in a paused RNA polymerase</article-title>. <source>Mol. Cell</source>. <year>2013</year>; <volume>50</volume>:<fpage>882</fpage>&#x02013;<lpage>893</lpage>.<pub-id pub-id-type="pmid">23769674</pub-id>
</mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hein</surname> &#x000a0;<given-names>P.P.</given-names></string-name>, <string-name><surname>Kolb</surname> &#x000a0;<given-names>K.E.</given-names></string-name>, <string-name><surname>Windgassen</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Bellecourt</surname> &#x000a0;<given-names>M.J.</given-names></string-name>, <string-name><surname>Darst</surname> &#x000a0;<given-names>S.A.</given-names></string-name>, <string-name><surname>Mooney</surname> &#x000a0;<given-names>R.A.</given-names></string-name>, <string-name><surname>Landick</surname> &#x000a0;<given-names>R.</given-names></string-name></person-group> &#x000a0;<article-title>RNA polymerase pausing and nascent-RNA structure formation are linked through clamp-domain movement</article-title>. <source>Nat. Struct. Mol. Biol.</source> &#x000a0;<year>2014</year>; <volume>21</volume>:<fpage>794</fpage>&#x02013;<lpage>802</lpage>.<pub-id pub-id-type="pmid">25108353</pub-id>
</mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Werner</surname> &#x000a0;<given-names>F.</given-names></string-name>
</person-group> &#x000a0;<article-title>A nexus for gene expression-molecular mechanisms of Spt5 and NusG in the three domains of life</article-title>. <source>J. Mol. Biol.</source> &#x000a0;<year>2012</year>; <volume>417</volume>:<fpage>13</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">22306403</pub-id>
</mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Benjamini</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Krieger</surname> &#x000a0;<given-names>A.M.</given-names></string-name>, <string-name><surname>Yekutieli</surname> &#x000a0;<given-names>D</given-names></string-name></person-group> &#x000a0;<article-title>Adaptive linear step-up procedures that control the false discovery rate</article-title>. <source>Biometrika</source>. <year>2006</year>; <volume>93</volume>:<fpage>491</fpage>&#x02013;<lpage>507</lpage>.</mixed-citation></ref></ref-list></back></article>